fbpx

Search NGU Website

Academics

Academics

School of Pharmacy

About the school:
Through collaborating with UCL School of pharmacy, ranking 4th on the world, Newgiza University utilizes existing UCL teaching and assessment resources, delivering the NGU program that produces distinctive NGU Pharmacists.

Vision:

Create a community of interdisciplinary researchers, professors and students who foster excellence and encourage innovation. This community will spearhead academic and scientific advancement in the region and across the world by building a solid foundation for the 21st century learning.

Mission:
The School of Pharmacy – Newgiza University aims to prepare graduates with competitive competencies who are able to meet the requirements of the pharmaceutical labor market locally and internationally, patient-centered, contribute to raise the health care level, relying on qualified human cadres, a distinguished international educational program, a supportive environment for innovation and scientific research, and active participation in community service while preserving social values.

 

Dr. Manal Maher,
Dean of the School of Pharmacy

As the first dean and founder of the Newgiza University School of Pharmacy, Prof. Manal Mohamed Maher Hussein has been committed to graduating future leaders and advancing the pharmacy practice. Prior to becoming the dean in 2016, Prof. Manal is a professor of microbiology and immunology and held several positions at the Faculty of Pharmacy, Cairo University including, Acting Dean (7/2014-12/2014); Vice-Dean for Education and Students Affairs (2011-2016); Coordinator of the Clinical Pharmacy Program (2009-2011). Dr. Maher participated in the implementation of the Clinical Pharmacy Program until the first graduated class in 2011.
She is a former member of the Promotion Committee of Professors and Associate Professors for Microbiology and Immunology.
Her research areas of interest are microbial resistance, fermentation technology, and the development of new vaccines and biotechnological products. Dr. Manal was the PI investigator in two research projects covering the process development for the industrial production of Rifamycin B and the feasibility study for a cost-effective process for the production of Rifamycin B. Awarded a Patent No. (200312062) titled “Process for Production of Rifamycin B using improved bacterial strain”

1. Continuous development of the educational process, students support, and enhance competitiveness.

2. Enhancement of the institutional capacity and development of the institutional evaluation systems.

3. Development of scientific research and creating postgraduate programs.

4. Enhancement of the community role of the school and supporting graduates.

1. Qualify the school to apply for accreditation from the National Authority for Quality Assurance and Accreditation of Education “NAQAAE”.

2. Review and develop the educational programme.

3. Continuous development of the capabilities of staff members and TAs.

4. Continuous development of the student support system to build a distinguished personality capable of competing locally and internationally.

5. Enhance the competitive position of the school.

6. Continue to support and develop the infrastructure.

7. Develop the organizational structure and the capabilities of the administrative staff.

8. Develop the quality management system and self-assessment.

9. Support the research environment within the school.

10. Support excellence and innovation in scientific research and encourage international publication, joint, and applied research.

11. Start offering postgraduate programs.

12. Develop and support community service activities.

13. Serve the internal environment and deal effectively with crises and disasters.

14. Support and communicate with alumni.

1. Honesty

2. Respect and teamwork support

3. Scientific integrity

4. Discipline, capacity building, and continuous development

5. Compassion

6. Fairness, justice, and transparency

7. Diversity

8. Excellent professional performance

9. Creativity and innovation

  • A modern, fit-for-purpose course adapted directly from that delivered by UCL, one of the world’s top pharmacy schools (ranked 4th Worldwide).
  • Course designed with University College London (UCL) to provide the professional experience, knowledge, and leadership skills that UCL students enjoy, delivered in a context relevant to the region.
  • Inter-professional education to allow pharmacy students to learn alongside medical and dental students, leading to greater cooperation with the healthcare team and enhanced patient care.
  • Research-focused module that delivers an intimate exposure to research techniques with different outcomes as posters and published manuscripts.
  • Incorporating clinical pharmacy from the very first year, accounting for over 25% of the entire curriculum, with state-of-the-art training facilities on-campus with a modern teaching dispensary.
  • Emphasis on producing leaders with the skills to embrace the future direction of the profession.
  • Emphasizing on experiential learning in placements including JCI-accredited hospitals, community pharmacies, and industrial pharmaceutical companies, as well as in the classroom to produce future leaders of the profession.
  • A newly built university in a beautiful setting, purpose-designed to enhance the student experience in healthcare subjects.
  • Flipped classroom approach in the senior year via self-study on cutting edge topics.
  • A vibrant on-campus student life with numerous clubs, events, and activities offering a unique environment to explore the students’ hidden talents.
  • Provides valuable opportunities to start with their careers by organizing fairs and internships giving students a significant advantage in their professional journeys.
  • Maintaining a low student-to-teacher ratio, enabling dedicated attention to student progress and success, in addition to providing academic support throughout their degree programs.

Accreditation:

Newgiza University (NGU) was established as a private university by a presidential Decree “93” in April 2010. NGU schools were acknowledged by the Ministry of Higher Education (MHE) and the Supreme Council of Universities (SCU).

The university will eventually include twelve schools: Medicine; Pharmacy; Dentistry; Nursing and Health Science; Economics and Politics; Law; Business and Finance; Engineering; Information Technology; Fine Arts; Archaeology; and Languages and Interpretation. Currently, eight schools are functioning (Medicine, Dentistry, Pharmacy, Business and Finance, Economics and Politics, Engineering, Information Technology, and Fine Arts).

The School of Pharmacy was acknowledged by decree “4565” in September 2016. Every school will apply for accreditation by National Authority for Quality Assurance and Accreditation in Education (NAQAAE) after the graduation of the first batch.

University College London (UCL):

The School of Pharmacy at NGU has an academic collaboration with University College London (UCL), enhancing its academic capabilities, as well as offering world-renowned undergraduate program, providing both the school and students with ample opportunities for development on an academic and personal level.

This collaboration ensured that the highest international standards in teaching and research are met at NGU, with highly qualified faculty members providing instruction and supervision. As part of this collaboration, senior faculty, and staff from UCL worked with their NGU colleagues in strategic planning and organization of the new programs, setting up appropriate infrastructure and education governance structures, developing curricula and learning resources, faculty and senior staff recruitment, faculty development, course evaluation and education quality assurance. Where appropriate, NGU utilizes existing UCL teaching and assessment resources to deliver its programs.

Having currently ranked 9th on the QS World University Rankings 2024, and consistently placing in the top 20 of various global university rankings, UCL is widely recognized for its research capabilities and contributions to sciences and innovations. It was rated 2nd in the UK for research power in the Research Excellence Framework 2021. Moreover, UCL boasts 30 Nobel Prize winners, and was recently selected as University of the Year 2024 (The Times and Sunday Times Good University Guide 2024).

The UCL School of Pharmacy is one of the most highly rated pharmacy schools in the UK. It is currently rated 4th in the world by the QS Ranking (Pharmacy and Pharmacology 2023), as well as 3rd in the Shanghai Ranking (Pharmacy and Pharmaceutical Science 2022).

The NGU BPharm (PharmD) is five academic years in duration (10 semesters) and a year of residency training (year of excellence). This includes an Introductory Semester that is shared with other health education programs at NGU (Medicine and Dentistry).  Successful completion of the five-year program and spending the year of residency training (year of excellence), will result in the award of the BPharm (PharmD).

The program contains 198 credit units (20 credit units per semester for 9 semesters, plus 18 credit units for the introductory semester).  These credit units do not represent only contact hours but the total learning effort required to achieve the learning outcomes including direct contact hours in classrooms, small groups and practical classes, workplace-based learning in clinical placements, project work and self-directed learning.  A credit unit is considered to be equivalent to 25-30 hours of study time.

The assessment approach has been designed alongside the curriculum that embraces the following key principles:
a) Formative assessment: Students take formative tests throughout the modules running all through the program.
b) Summative assessments: May take the form of written examinations, coursework, portfolio or reports (e.g. Elective) at the end of each semester.
c) Practical/Objective: Structured Clinical Examinations (P/OSCEs)

MODULES:
Year 1: Semester 1: Introductory module
Semester 1: Introductory module (IM 1.1.1)
Includes underpinning basic sciences, basic communication skills, English language skills, in addition to orientation for a career in healthcare.
Year 1: Semester 2:
PHAR101: The role of pharmacists in healthcare
Introduces students to their future role as pharmacists and to the current and evolving pharmacy profession. A “Top 25” drug list is introduced.
PHAR102: Body systems and therapeutics 1.
Provides a solid foundation of the biological sciences that underpin the clinical therapeutic uses of a drug, also introducing and discussing cell biology and biochemistry, cell and organ system function, whole-body physiology and pharmacology.

Year 2: Semester 1
PHAR 201: Chemistry of medicines
Provides a solid foundation of the chemical sciences underpinning the use of a drug in its broadest sense, in addition to introducing and discussing organic, physical and analytical chemistry concepts in detail.
PHAR 202: Making safe and effective medicines
Formulation and manufacture of safe and effective medicines, both sterile and non-sterile, with particular emphasis on liquid and semi-solid systems.
Year 2: Semester 2:
PHAR 203: Clinical and professional considerations
The knowledge, skills, and attitudes required for pharmacy practice are further developed throughout the module.
The “Top 25” drugs will be extended to a “Top 50”
PHAR 204: Body Systems and Therapeutics 2
Concentrates on the cardiovascular, renal, and endocrine systems, providing a solid underpinning knowledge of the structure and function of these body systems. Discussing the concept of clinical therapeutics, demonstrating how drug utilization is firmly grounded in the pharmaceutical and pharmacological sciences.

Year 3: Semester 1
PHAR 301: Body Systems and Therapeutics 3
Focuses on the central nervous system; gastro-intestinal system, liver, skin and eye, and at the same time providing a solid underpinning knowledge of the structure and function of these body systems.
PHAR 302: Medicines from the bench to the clinic
Describes the processes involved in the discovery, development, and testing of a new molecule, i.e. its journey from the laboratory bench to clinical use.
Year 3: Semester 2
PHAR 303: Body Systems and Therapeutics 4
Focuses on the immune system, disease relating to inflammation, infectious diseases, respiratory diseases, and cancer, providing a solid foundation of the relevant biological principles.
PHAR 304: Communicating science and practice
Further prepares students for their future role as pharmacists for the current and evolving pharmacy profession.
The “Top 50” drug list is extended in this module to a “Top 75”.

Year 4: Semester 1
PHAR 401: Future design and delivery of medicines
Explores some of the more advanced technologies used in the discovery and formulation of new drug molecules and production of the formulated product.
PHAR 402: Life skills and professional skills
Sound knowledge of research methodology is vital for modern healthcare professionals, as is the ability to apply research and evaluative skills in practice. This module also develops students’ personal skills in areas such as written and oral communication.
Year 4: Semester 2
PHAR 403: Options (Electives)
Each student selects two options; one from strand A which comprises broad areas, whereas strand B comprises specific topics.
PHAR 404: Experiential placement
An experiential placement is a mandatory requirement for graduation in Egypt, hence, this ensures that suitable high-quality experiences are available for all students.

Year 5: Semester 1
PHAR 501: Independent research project
Includes the design, implementation, and delivery of a research project. The projects may be laboratory-based or practice-based or data/literature/theory-based. Each student has an individual project and is assessed individually.
Year 5: Semester 2
PHAR 502: Advancing practice through science
New advances in science and practice while revisiting topics previously covered in the course.
PHAR 503: Preparation for professional practice
Describes current and future roles in pharmacy and prepares students for practice.
The “Top 75” drugs list is extended to a “Top 100”.

Year 6: (year of residency training) (year of excellence)
Waiting for instructions and specifications from The Supreme Council of Universities in Egypt.

Research Lab:
The School of Pharmacy (SOP) currently has two state-of-the-art research facilities, where multi-disciplinary research groups are able to conduct ground-breaking research.

Research Areas:

1.      Pharmacotherapy role in improvement of disease outcomes
2.      Therapeutic Drug Monitoring.
3.      Drug interactions.
4.      Pharmacogenomics.
5.      Nutrigenomics.
6.      Pharmacoeconomics.
7.      Herbal medicines and tissue culture.
8.      Standardization of drugs.
9.      Formulation and evaluation of nano-drug delivery systems.
10.  Biopharmaceuticals (Biosimilars, Bioinformatics, Gene therapy, and recombinant DNA).
11.  Water resources.
12.  Cancers.
13.  Hepatic diseases.
14.  Metabolic disorders (Obesity and Diabetes).
15.  Cardiovascular diseases (Hypertension).
16.  Central nervous system and neurodegenerative diseases.
17.  Infectious diseases.
18.  Development and fabrication of Advanced Drug Delivery.
19.  Targeted Drug Delivery systems.
20.  Biopharmaceutics and Pharmacokinetics optimization.
21.  Patient centric formulations.

 

Projects and Grants:

1.NRC project: repurposing antivirals as novel anticancer drugs targeting structural and functional similarities between viral proteins and cancers.

Dr. Sally Atef

2. Project code: 13010103, “Design, synthesis and molecular modeling of new organophosphorus compounds as multifunctional ligands for treatment of Alzheimer’s disease”, National Research Centre (NRC), July 2022 to June 2024.

Dr. Marwa Fouad

3. ASRT, Academy of Scientific Research and Technology, Egypt

Ahmed S. Attia (PI), Medhat Al-Ghobashy & Noha Elhosseiny

“The production of nanobodies using the yeast display technology as a              non-conventional tool for precision medicine in infective diseases &                beyond.”

December 2020 – Running

4. ASRT, Academy of Scientific Research and Technology, Egypt

Grant Code: KTA-C4-4267

Ahmed ElKerdawy

“Towards the Establishment of a Globally Compliant Egyptian Active Pharmaceutical Ingredient Facility for Critical Diseases”

April 2020 – Running

5. STDF-RSG, Science & Technology Development Fund, Egypt

Grant Code: 34848

Ahmed ElKerdawy

“Development of Novel EGF Receptor Inhibitors Targeting Non-Small Cell Lung Cancer (NSCLC)”

October 2019 – Running

6. STDF-RSG, Science & Technology Development Fund, Egypt

Grant Code: 30069

Ahmed ElKerdawy

“Design, Synthesis, and Biological Evaluation of Novel Raf -1/VEGFR-2 Inhibitors as Antiangiogenic Agents”

October 2019 – Running

7. STDF-RSG, Science & Technology Development Fund, Egypt

Grant Code: 34859

Ahmed ElKerdawy

“Synthesis and biological evaluation of novel fibrates as antihyperlipidemic agents”

October 2019 – Running

8. STDF, Science & Technology Development Fund, Egypt

Medhat Al-Ghobashy (PI), Ahmed Attia (Co-PI), Basma Eltanany & Mohamed Abdullah

“Assessment of biosimilarity and interchangeability of locally produced biopharmaceuticals using statistically-guided orthogonal testing protocols at industrial scale”

May 2019 – Running

9. ASRT, Academy of Scientific Research and Technology, Egypt

Nesrine Salah El Dine El-Sayed (PI), Salwa Ahmed Elgebaly, Medhat Al-Ghobashy, Galal Elgemeie & Mamdouh A. Abu-Zaied

“To Determine the Capability of the Cardioprotective Cyclocreatine Phosphate to Reduce the Progression of Myocardial Infarction to Heart Failure in the Standard ISO Rat Model”

November 2018 – Running

10. Bilateral project: NRC, National Research Centre & CNR, Istituto di Chimica del Riconoscimento Molecolare

Project code: IT II 020702

Ahmed ElKerdawy

“Design, Synthesis and Biological Evaluation of Novel Chalcone-based Fibrates as Novel PPAR-α Agonists”

March 2018 – Closed.

11. STDF, Science & Technology Development Fund, Egypt

Project code: STDF 15063

Ahmed ElKerdawy

“Development of Novel VEGF Tyrosine Kinase Receptor Antagonists Utilizing Molecular Modeling Techniques”

March 2017 – Closed.

12. STDF, Science & Technology Development Fund, Egypt

Medhat Al-Ghobashy (PI), Aliaa El-Meshad (Co-PI), Ahmed Attia, Wael Mamdouh, Muhammad Al-Shorbagy, & Mohamed Abduallah

“Formulation and Evaluation of Surface Functionalized Nanoparticles Enclosing Myelin Basic Protein for Treatment of Multiple Sclerosis”

April 2016 – Closed.

 SOP Publications    Total 172  Total citations 1956
  Publication IF Citations
1. Fahim SA, Ibrahim S, Tadros SA, Badary OA. Protective effects of butylated hydroxytoluene on the initiation of N-nitrosodiethylamine-induced hepatocellular carcinoma in albino rats. Hum Exp Toxicol. 2023 Jan-Dec;42:9603271231165664.

 

doi: 10.1177/09603271231165664.

2.8 1
2. Badr AM, Elkholy O, Said M, Fahim SA, El-Khatib M, Sabry D, Gaber RM. Diagnostic significance of hsa_circ_0000146 and hsa_circ_0000072 biomarkers for Diabetic Kidney Disease in patients with type 2 diabetes mellitus. J Med Biochem. 2023 Mar 15;42(2):239-248.

doi: 10.5937/jomb0-39361.

2.5 0
3. ElMonier AA, El-Boghdady NA, Fahim SA, Sabry D, Elsetohy KA, Shaheen AA. LncRNA NEAT1 and MALAT1 are involved in polycystic ovary syndrome pathogenesis by functioning as competing endogenous RNAs to control the expression of PCOS-related target genes. Noncoding RNA Res. 2023 Mar 3;8(2):263-271.

doi: 10.1016/j.ncrna.2023.02.008.

5 2
4. Shimaa Abdelsattar *, Sally A. Fahim, Hiba S Al-Amodi, Hala F.M. Kamel, Zeinab A. Kasemy, Fatma O. Khalil, Mahmoud S. Abdallah, Hanan M Bedair, Abd El-Naser Abd El-Ati Gad Alla, Alyaa Sabry, Mohamed A. Sakr, Mahmoud Selim, Eman M. Abd Elgayed. The Potential Role of Circulating Long miscellaneous RNAs in the Diagnosis and Prognosis of hepatitis C related Hepatocellular Carcinoma. Non-Coding RNA. 2023 4.5 0
5. Ewaisha, R., & Anderson, K. S. Immunogenicity of CRISPR therapeutics—Critical considerations for clinical translation. Frontiers in Bioengineering and Biotechnology. 2023, volume 11.

doi:10.3389/fbioe.2023.1138596

5.7 2
6. Mariam Omara, Mohamed Hagras, Mohamed M Elsebaie, Nader S Abutaleb, Hanzada T Nour El-Din, Maria O Mekhail, Ahmed S Attia, Mohamed N Seleem, Marwa T Sarg, Abdelrahman S Mayhoub.  Exploring novel aryl/heteroaryl-isosteres of phenylthiazole against multidrug-resistant bacteria. RSC Adv.  2023 Jul 6;13(29):19695-19709.

doi: 10.1039/d3ra02778c.

3.9 1
7. Essam, R.M., Saadawy, M.A., Gamal, M., Abdelsalam, R.M., El-Sahar, A.E. Lactoferrin averts neurological and behavioral impairments of thioacetamide-induced hepatic encephalopathy in rats via modulating HGMB1/TLR-4/MyD88/Nrf2 pathway. Neuropharmacology, 2023, 236, 109575.

 

doi: 10.1016/j.neuropharm.2023.109575

4.7 0
8. El-Sahar, A.E., Bekhit, N., Eissa, N.M., Abdelsalam, R.M., Essam, R.M. Targeting HMGB1/PI3K/Akt and NF-κB/Nrf-2 signaling pathways by vildagliptin mitigates testosterone-induced benign prostate hyperplasia in rats. Life Sciences, 2023, 322, 121645

doi: 10.1016/j.lfs.2023.121645.

6.1 2
9. Abdalhameid, E., Abd El-Haleim, E.A., Abdelsalam, R.M., Fawzy, H.M., Kenawy, S.A.  Cinnamic acid mitigates methotrexate-induced lung fibrosis in rats: comparative study with pirfenidone. Naunyn-Schmiedeberg’s Archives of Pharmacology, 2023.

doi: 10.1007/s00210-023-02652-w.

3.6 0
10. Mai A Abd-Elmawla, Reham M Essam, Kawkab A Ahmed, Maha Abdelmonem. Implication of Wnt/GSK-3β/β-Catenin Signaling in the Pathogenesis of Mood Disturbances Associated with Hyperthyroidism in Rats: Potential Therapeutic Effect of Naringin. ACS Chem Neurosci. 2023;14(11):2035-2048.

doi: 10.1021/acschemneuro.3c00013.

5 4
11. Eman M Elbaz, Reham M Essam, Kawkab A Ahmed, Maheera H Safwat. Donepezil halts acetic acid-induced experimental colitis in rats and its associated cognitive impairment through regulating inflammatory/oxidative/apoptotic cascades: An add-on to its anti-dementia activity. Int Immunopharmacol. 2023, 116:109841.

doi: 10.1016/j.intimp.2023.109841

5.6 4
12. Reham M Essam, Esraa A Kandil. p-CREB and p-DARPP-32 orchestrating the modulatory role of cAMP/PKA signaling pathway enhanced by Roflumilast in rotenone-induced Parkinson’s disease in rats. Chem Biol Interact. 2023 25:372:110366.

doi: 10.1016/j.cbi.2023.110366

5.1 1
13. Mona M Saber, Manal Moustafa Mahmoud, Hesham M Amin, Reham M Essam. Therapeutic effects of combining curcumin and swimming in osteoarthritis using a rat model. Biomed Pharmacother. 2023 166:115309.

doi: 10.1016/j.biopha.2023.115309.

7.5 0
14. Shohda A El-Maraghy, Aya Reda, Reham M Essam, Mona A Kortam. The citrus flavonoid “Nobiletin” impedes STZ-induced Alzheimer’s disease in a mouse model through regulating autophagy mastered by SIRT1/FoxO3a mechanism. Inflammopharmacology 2023;31(5):2701-2717.

doi: 10.1007/s10787-023-01292-z.

5.8 0
15. Hanan H. Ahmed, Reham M. Essam, Muhammed F. El-Yamany, Kawkab A. Ahmed and Ayman E. El-Sahar. Unleashing lactoferrin’s antidepressant potential through the PI3K/Akt/mTOR pathway in chronic restraint stress rats. Food Funct. 2023

doi: 10.1039/d3fo02222f.

6.1 0
16. Hebatollah E Eitah, Hanan Naeim Attia, Ahmed A F Soliman, Amina A Gamal El Din, Khaled Mahmoud, Rabab H Sayed, Yousreya A Maklad, Ayman E El-Sahar.  Vitamin D ameliorates diethylnitrosamine-induced liver preneoplasia: A pivotal role of CYP3A4/CYP2E1 via DPP-4 enzyme inhibition. Toxicol Appl Pharmacol. 2023  1:458:116324.

doi: 10.1016/j.taap.2022.116324.

3.8 0
17. El-Hussieny, M., Abd-El-Maksoud, M.A., Soliman, F.M., Fouad, M.A., El-Ashrey, M.K. Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and β-amyloid aggregation. Journal of Enzyme Inhibition and Medicinal Chemistry, (2023) 38 (1), art. no. 2166040.

DOI: 10.1080/14756366.2023.2166040

5.6 1
18. Ola Ahmed Saleh, Amr Mohamed Badawey, Hassan Y. Aboul Enein and Marwa Ahmed Fouad. Enantioseparation, quantification, molecular docking and molecular dynamics study of five β adrenergic blockers on Lux Cellulose 2 column. BMC Chemistry, (2023) 17 (1), art. no. 22.

DOI: 10.1186/s13065-023-00925-2.

4.6 0
19. Salem, W.A., Elkady, E.F., Fouad, M.A., Mohammad, M.A.-A. DoE Screening and Optimization of Liquid Chromatographic Determination of Nicotinic Acid and Six Statins: Application to Pharmaceutical Preparations and Counterfeit Detection. Journal of chromatographic science, (2023) 61 (1), pp. 74-86.

DOI: 10.1093/chromsci/bmab131.

1.3 2
20. Abdel Rahman, D.E., Fouad, M.A., Mohammed, E.R., El-Zoheiry, H.H., Abdelrasheed Allam, H. Novel VEGFR-2 inhibitors as antiangiogenic and apoptotic agents via paracrine and autocrine cascades: Design, synthesis, and biological evaluation. Bioorganic Chemistry, (2023) 139, 106678.

doi: 10.1016/j.bioorg.2023.106678.

5.1 0
21. Ezzat, M.A.F., Abdelhamid, S.M., Fouad, M.A., Abdel-Aziz, H.A., Allam, H.A. Design, synthesis, in vitro, and in vivo evaluation of novel phthalazinone-based derivatives as promising acetylcholinesterase inhibitors for treatment of Alzheimer’s disease. Drug Development Research, (2023) 84(6), pp. 1231–1246.

doi: 10.1002/ddr.22082.

3.8 0
22. Ezzat, M.A.F., Elmasry, G.F., El-Mageed, M.M.A.A., Fouad, Marwa A., Abdel-Aziz, H.A., Elewa, S.I. Design, synthesis, and biological evaluation of furan-bearing pyrazolo[3,4-b]pyridines as novel inhibitors of CDK2 and P53–MDM2 protein–protein interaction. Drug Development Research, (2023) 84(6), pp. 1183–1203

doi: 10.1002/ddr.22079

3.8 0
23. Ahmed, R.F., Mahmoud, W.R., Abdelgawad, N.M., Fouad, M.A., Said, M.F. Exploring novel anticancer pyrazole benzenesulfonamides featuring tail approach strategy as carbonic anhydrase inhibitors. European Journal of Medicinal Chemistry, (2023) 261, 115805.

doi: 10.1016/j.ejmech.2023.115805.

6.7 0
24. Ehab Elkady, Marwa Fouad, Ayoub Mozayad. Application of Box–Behnken Design and Response Surface Methodology for Selecting the Optimum RP-HPLC Conditions for the Simultaneous Determination of Paracetamol and Diclofenac Sodium Along With Three Skeletal Muscle Relaxants in Three Different Pharmaceutical Dosage Forms. Journal of chromatographic science, (2023) In press.

DOI: doi.org/10.1093/chromsci/bmad051

1.3 2
25. Rania S M Ismail, Ahmed M El Kerdawy, Dalia H Soliman, Hanan H Georgey, Nagwa M Abdel Gawad, Andrea Angeli, Claudiu T Supuran. Discovery of a new potent oxindole multi-kinase inhibitor among a series of designed 3-alkenyl-oxindoles with ancillary carbonic anhydrase inhibitory activity as antiproliferative agents. BMC Chem 2023 Jul 18;17(1):81.

doi: 10.1186/s13065-023-00994-3.

4.6 2
26. Iman A Y Ghannam, Ahmed M El Kerdawy, Marwa M Mounier, Mahmoud T Abo-Elfadl, Islam H Ali. Novel 2-oxo-2-phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR-2 inhibitors: Design, synthesis, and anticancer evaluation. Arch Pharm (Weinheim) 2023 Feb;356(2):e2200341.

doi: 10.1002/ardp.202200341.

5.1 1
27. Heba T Abdel-Mohsen, Ahmed M El Kerdawy, Andrea Petreni, Claudiu T Supuran. Novel benzenesulfonamide-thiouracil conjugates with a flexible N-ethyl acetamide linker as selective CA IX and CA XII inhibitors. Arch Pharm (Weinheim) 2023 Feb;356(2):e2200434.

doi: 10.1002/ardp.202200434.

5.1 1
28. Yomna I El-Gazzar, Heba R Ghaiad, Ahmed M El Kerdawy, Riham F George, Hanan H Georgey, Khairia M Youssef, Hussein I El-Subbagh. New quinazolinone-based derivatives as DHFR/EGFR-TK inhibitors: Synthesis, molecular modeling simulations, and anticancer activity. Arch Pharm (Weinheim) 2023 Jan;356(1):e2200417.

doi: 10.1002/ardp.202200417

5.1 3
29. Sandy N Aziz , Alia A Badawy , Demiana I Nessem , Nevine S Abd El Malak , Marianne J Naguib. Chitosan-coated alginate (CCA) nanoparticles for augmentation of topical antihistaminic activity of diphenhydramine: in-vitro optimization, skin histopathology and pharmacodynamic studies with in vitro/in vivo correlation. Drug development &industrial pharmacy. 2023 Apr;49(4):316-327.

doi: 10.1080/03639045.2023.2211672.

3.4 0
30. Reham Hammad, Rania Sanad, Nevine S. Abd El Malak, Randa Latif, Cubosomal-functionalized block copolymer platform for dual delivery of linagliptin and empagliflozin: Recent advances in synergistic strategies for maximizing control of high-risk type II diabetes Drug Delivery and Translational Research.2023 5.4 0
31. Salah, M.; Tahoun, M.; Rudzitis-Auth, J.; Stotz, L.; van Koppen, C. J.; Laschke, M. W.; Abdelsamie, A. S.; Frotscher, M. Potent Dual Inhibitors of Steroid Sulfatase and 17βHydroxysteroid Dehydrogenase Type 1 with a Suitable Pharmacokinetic Profile for In Vivo Proof-of-Principle Studies in an Endometriosis Mouse Model. J. Med. Chem. 2023, 66 (13), 8975–8992.

doi: 10.1021/acs.jmedchem.3c00571.

6.7 0
Serial Publications IF Citations
32.      Naglaa F. El-Sayed, Marwa El-Hussieny, Ewies F. Ewies, Mohamed F. El Shehry, Hanem M. Awad, Marwa A. Fouad. “Design, synthesis, biological evaluation, and molecular docking of new benzofuran and indole derivatives as tubulin polymerization inhibitors”, Drug Development Research, 83(2), 485-500, (2022).

DOI: 10.3390/molecules27175501.

5.004 0
33.      Asmaa Raafat, Samar Mowafy, Sahar M. Abouseri, Marwa A. Fouad, Nahla A. Farag. “Lead generation of cysteine based mesenchymal epithelial transition

(c-Met) kinase inhibitors: Using structure-based scaffold hopping, 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamics simulation”, Computers in Biology and Medicine, 146, 105526, (2022).

DOI: doi.org/10.1016/j.compbiomed.2022.105526

6.698 1
34.      Ewies, Ewies F.; Sabry, Eman; Bekheit, Mohamed S.; Fouad, Marwa A.; Vullo, Daniela; Supuran, Claudiu T. “Click chemistry-based synthesis of new benzenesulfonamide derivatives bearing triazole ring as selective carbonic anhydrase II inhibitors”, Drug Development Research, (2022) In press.

DOI: doi: 10.1002/ddr.21957

5.004 2
35.      El-Kersh, Dina M.; Abou El-Ezz, Rania F.; Fouad, Marwa; Farag, Mohamed A. “Unveiling Natural and Semisynthetic Acylated Flavonoids: Chemistry and Biological Actions in the Context of Molecular Docking”, Molecules, 27:5501, (2022)

DOI: 10.3390/molecules27175501

4.927 0
36.      Fouad, Marwa A.; Serag, Ahmed; Tolba, Enas H.; El-Shal, Manal A.; El Kerdawy, Ahmed M. “QSRR modeling of the chromatographic retention behavior of some quinolone and sulfonamide antibacterial agents using firefly algorithm coupled to support vector machine”, BMC Chemistry, 16, 85, 2022

DOI: 10.1186/s13065-022-00874-2

4.095 0
37.      Elkady, Ehab F.; Fouad, Marwa A.; Mozayad, Ayoub N. “Application of Box-Behnken experimental design and response surface methodology for selecting the optimum RP-HPLC conditions for the simultaneous determination of methocarbamol, indomethacin and betamethasone in their pharmaceutical dosage form”, BMC Chemistry 16, 114 (2022)

DOI: 10.1186/s13065-022-00908-9

4.095 0
38.      Wadhah Atef Salem, Ehab Farouk Elkady, Marwa Ahmed Fouad, Mohammad Abdul-Azim Mohammad. “DoE Screening and Optimization of Liquid Chromatographic Determination of Nicotinic Acid and Six Statins: Application to Pharmaceutical Preparations and Counterfeit Detection” J Chromatogr. Sci. 29;61(1):74-86 (2022)

DOI: 10.1093/chromsci/bmab131.

1.555 0
39.      El-Gazzar YI, Ghaiad HR, El Kerdawy AM, George RF, Georgey HH, Youssef KM, El-Subbagh HI.Arch Pharm (Weinheim). New quinazolinone-based derivatives as DHFR/EGFR-TK inhibitors: Synthesis, molecular modeling simulations, and anticancer activity. Arch Pharm (Weinheim). 18:e2200417. (2022)

DOI:  10.1002/ardp.202200417.

4.613 0
40.      Ali IH, Abdel-Mohsen HT, Mounier MM, Abo-Elfadl MT, El Kerdawy AM, Ghannam IAY. Design, synthesis and anticancer activity of novel 2-arylbenzimidazole/2-thiopyrimidines and 2-thioquinazolin-4(3H)-ones conjugates as targeted RAF and VEGFR-2 kinases inhibitors. Bioorg. Chem. 126:105883 (2022)

DOI: 10.1016/j.bioorg.2022.105883.

5.307          1
41.   Al-Warhi T, El Kerdawy AM, Said MA, Albohy A, Elsayed ZM, Aljaeed N, Elkaeed EB, Eldehna WM, Abdel-Aziz HA, Abdelmoaz MA Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights. Drug Des Devel Ther.  16;16:1457-1471 (2022)

DOI: 10.2147/DDDT.S356988.

4.319 1
42.   Hassan RM, Ali IH, Abdel-Maksoud MS, Abdallah HMI, El Kerdawy AM, Sciandra F, Ghannam IAY.  Design and synthesis of novel quinazolinone-based fibrates as PPARα agonists with antihyperlipidemic activity. Arch Pharm (Weinheim), 355(3):e2100399 (2022).

DOI: 10.1002/ardp.202100399

4.319 1
43.   Abdel-Mohsen HT, El Kerdawy AM, Omar MA, Petreni A, Allam RM, El Diwani HI, Supuran CT Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine-Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors. Eur J Med Chem. 15;228:114004 (2022).

DOI: 10.1016/j.ejmech.2021.114004.

7.088 7
44.   Iman A. Y. Ghannam, Ahmed M. El Kerdawy, Marwa M. Mounier, Mahmoud T. Abo‐elfadl, Islam H. Ali  Novel 2‐oxo‐2‐phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR‐2 inhibitors: Design, synthesis, and anticancer evaluation Arch Pharm (Weinheim), e2200341 (2022)

DOI: 10.1002/ardp.202200341

4.613 0
45.   Heba T. Abdel‐Mohsen, Ahmed M. El Kerdawy, Andrea Petreni, Claudiu T. Supuran Novel benzenesulfonamide‐thiouracil conjugates with a flexible N‐ethyl acetamide linker as selective CA IX and CA XII inhibitors Arch Pharm (Weinheim). 2022, e2200434.

DOI: 10.1002/ardp.202200434

4.613 0
46.   Wagdy M. Eldehna, Raed M. Maklad, Hadia Almahli, Tarfah Al-Warhi, Eslam B. Elkaeed, Mohammed A. S. Abourehab, Hatem A. Abdel-Aziz and Ahmed M. El Kerdawy. Identification of 3-(piperazinylmethyl) benzofuran derivatives as novel type II CDK2 inhibitors: design, synthesis, biological evaluation, and in silico insights. J Enz. Inhib. Med. Chem.  37(1), 1227–1240 (2022).

DOI: 10.1080/14756366.2022.2062337.

5.756 5
47.   Eman A. Abd El-Meguid, Ahmed M. Naglah, Gaber O. Moustafa, Hanem M. Awad, Ahmed M. El Kerdawy Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies Bioorg. Med.l Chem. Lett. 58, 128529 (2022).

DOI: 10.1016/j.bmcl.2022.128529.

2.940 4
48.   El Gizawy HA, El-Haddad AE, Saadeldeen AM, Boshra SA. Tentatively Identified (UPLC/T-TOF-MS/MS) Compounds in the Extract of Saussurea costus Roots Exhibit In Vivo Hepatoprotection via Modulation of HNF-1α, Sirtuin-1, C/ebpα, miRNA-34a and miRNA-223. Molecules, 28;27(9):2802 (2022).

DOI: 10.3390/molecules27092802.

4.927 3
49.   El Gizawy HA, El-Haddad AE, Attia YM, Fahim SA, Zafer MM, Saadeldeen AM. In Vitro Cytotoxic Activity and Phytochemical Characterization (UPLC/T-TOF-MS/MS) of the Watermelon (Citrullus lanatus) Rind Extract. Molecules. 12;27(8):2480 (2022).

DOI: 10.3390/molecules27082480.

4.927 0
50.   Wadhah Atef Salem, Ehab Farouk Elkady, Marwa Ahmed Fouad, Mohammad Abdul-Azim Mohammad. “Analysis of Metformin and Five Gliptins in Counterfeit Herbal Products: Designs of Experiment Screening and Optimization”, Journal of AOAC International, 104(6), 1667–1680, (2021).

DOI: 10.1093/jaoacint/qsab106

1.913 1
51.   El-Hussieny, M., El-Sayed, N.F., Fouad, M.A., Ewies, E.F. “Synthesis, biological evaluation and molecular docking of new sulfonamide-based indolinone derivatives as multitargeted kinase inhibitors against leukemia”, Bioorganic Chemistry, 117, 105421, (2021).

DOI: 10.1016/j.bioorg.2021.105421

5.725 1
52.   Fouad, M.A., Zaki, M.Y., Lotfy, R.A., Mahmoud, W.R. “Design, synthesis, biological evaluation, and molecular docking of new benzofuran and indole derivatives as tubulin polymerization inhibitors”, Drug Development Research, 2021, 1-16, (2021).

DOI: 10.1002/ddr.21880

4.360 0
53.   Mohammad Abdul-Azim Mohammad, Ehab Farouk Elkady, Marwa Ahmed Fouad, Wadhah Atef Salem. “DoE Screening and Optimization of Liquid Chromatographic Determination of Nicotinic Acid and Six Statins: Application to Pharmaceutical Preparations and Counterfeit Detection”, Journal of Chromatographic Science, 1-13, (2021).

DOI: 10.1093/chromsci/bmab131

1.618 0
54.   Abd El-Aal, May A., Medhat A. Al-Ghobashy, and Yasser S. El-Saharty. “Preparation and characterization of 96-well microplates coated with molecularly imprinted polymer for determination and biosimilarity assessment of recombinant human erythropoietin.”, Journal of Chromatography A, 1641, 462012, (2021), ISSN 0021-9673.

DOI:  https://doi.org/10.1016/j.chroma.2021.462012.

4.759 5
55.   Nadim, Ahmed H., May A. Abd El-Aal, Medhat A. Al-Ghobashy, and Yasser S. El-Saharty. “Facile imprinted polymer for label-free highly selective potentiometric sensing of proteins: case of recombinant human erythropoietin.”, Analytical and Bioanalytical Chemistry, 413, 3611–3623, (2021).

DOI: https://doi.org/10.1007/s00216-021-03325-4.

4.157 5
56.   Nadim, Ahmed H., May A. Abd El-Aal, Medhat A. Al-Ghobashy, and Yasser S. El-Saharty. “Optimization of Polydopamine Imprinted Polymer for Label Free Sensitive Potentiometric determination of Proteins: Application to Recombinant Human Erythropoietin Sensing in Different Matrices.”, Microchemical Journal, 167, 106333, (2021).

DOI: https://doi.org/10.1016/j.microc.2021.106333.

4.821 4
57.   Gamal, Mohammed, Heba-Alla H. Abd-ElSalam, Ibrahim A. Naguib, Medhat A. Al-Ghobashy, Hala E. Zaazaa, and M. Abdelkawy. “Green and cost-effective extraction techniques of quercetin from mixture of nutraceuticals with yield analysis via spectrophotometry and high performance liquid chromatograph methods.”, Journal of AOAC International, 18:qsab071, (2021). DOI: 10.1093/jaoacint/qsab071. 1.913 3
58.   Mahdally, N. H., George, R. F., Kashef, M. T., Al-Ghobashy, M., Murad, F. E., & Attia, A. S. “Staquorsin: A Novel Staphylococcus aureus Agr-Mediated Quorum Sensing Inhibitor Impairing Virulence in vivo Without Notable Resistance Development”, Frontiers in microbiology12, 700494, (2021).

DOI: https://doi.org/10.3389/fmicb.2021.700494.   

5.640 14
59.   Abanoub Mosaad Abdallah, Nadia G. Zaki, Walaa H. Mahmoud, Ahmed M. El Kerdawy, Gehad G. Mohamed. “Synthesis, structural characterization, density functional theory calculations, and antimicrobial, anticancer, and antimetastatic properties of nanosized heteroleptic complexes of cocaine/TMEDA with d-block metal ions.” App. Organometallic. Chem.,35: e6441 (2021).

DOI:  https://doi.org/10.1002/aoc.6441

4.105 1
60.   Rasha M. Hassan, Islam H. Ali, Mohammed S. Abdel-Maksoud , Heba M. I. Abdallah, Ahmed M. El Kerdawy, Francesca Sciandra, Iman A. Y. Ghannam. “Design and synthesis of novel quinazolinone-based fibrates as PPARα agonists with antihyperlipidemic activity” Arch. Pharm. (2021); e2100399

DOI: https://doi.org/10.1002/ardp.202100399

3.751 0
61.   Abdalla R. Mohamed, Ahmed M. El Kerdawy, Riham F. George, Hanan H. Georgey, Nagwa M. Abdel Gawad. “Design, synthesis and in silico insights of new 7,8-disubstituted-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione derivatives with potent anticancer and multi-kinase inhibitory activities”, Bioorganic Chemistry, 107, 104569, (2021).

DOI: https://doi.org/10.1016/j.bioorg.2020.104569.

5.725 8
62.   Eldehna WM, Al-Rashood ST, Al-Warhi T, Eskandrani RO, Alharbi A, El Kerdawy AM. “Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies”, J Enzyme Inhib Med Chem, 36(1), 270-285, (2021).

DOI:  10.1080/14756366.2020.1862101.

4.310 35
63.   Rasha M. Hassan, Mona E. Aboutabl, Manuela Bozzi, Mohammed F. El-Behairy, Ahmed M. El Kerdawy, Beatrice Sampaolese, Claudia Desiderio, Federica Vincenzoni, Francesca Sciandra, Iman A.Y. Ghannam. “Discovery of 4-benzyloxy and 4-(2-phenylethoxy) chalcone fibrate hybrids as novel PPARα agonists with anti-hyperlipidemic and antioxidant activities: Design, synthesis and in vitro/in vivo biological evaluation”, Bioorganic Chemistry,115, 105170, (2021). DOI: 10.1016/j.bioorg.2021.105170 5.725 2
64.   Heba Ibrahim, A. Abdo, Ahmed M. El Kerdawy, A. Sharaf Eldin. “Signal Detection in Pharmacovigilance: A Review of Informatics-driven Approaches for the Discovery of Drug-Drug Interaction Signals in Different Data Sources”, Artificial Intelligence in the Life Sciences1, 100005, (2021).

DOI: 10.1016/j.ailsci.2021.100005

——– 0
65.   Peter A. Halim, Hanan H. Georgey, Mina Y. George, Ahmed M. El Kerdawy, Mona F. Said. “Design and synthesis of novel 4-fluorobenzamide-based derivatives as promising anti-inflammatory and analgesic agents with an enhanced gastric tolerability and COX-inhibitory activity”, Bioorganic Chemistry,115, 105253, (2021).

DOI: 10.1016/j.bioorg.2021.105253

5.725 2
66.   Heba Ibrahim, Ahmed M. El Kerdawy, A. Abdo, A. Sharaf Eldin “Similarity-based machine learning framework for predicting safety signals of adverse Drug–Drug interactions”, Informatics in Medicine Unlocked, 100669, (2021).

DOI: 10.1016/j.imu.2021.100699.

2.110 5
67.   El-Haddad AE, El-Deeb EM, Amer AA, Saadeldeen AM, Ahmed FM, Salem MA, Taha HS. “Bioactive Phytoconstituents of Morus Plants exhibiting Numerous Therapeutic Activities”, Egyptian Journal of Chemistry, (2021).

DOI: 10.21608/EJCHEM.2021.76688.3788

——– 6
68.   El-Mancy, Shereen S., Alaadin E. El-Haddad, Walaa A. Alshareef, Amr M. Saadeldeen, Soad Z. El-Emam, and Osama S. Elnahas. “Enhancement of Antimicrobial and Antiproliferative Activities of Standardized Frankincense Extract Using Optimized Self-Nanoemulsifying Delivery System”, Scientia Pharmaceutica, 89(3), 36, (2021).

DOI: https://doi.org/10.3390/scipharm89030036.

——– 2
69.   Darwish, Amira Mohamed Galal, Hebatallah H. Abo Nahas, Yasmin H. Korra, Alaa A. Osman, Wedad M. El-Kholy, Maria Reyes-Córdova, Essa M. Saied, and Ahmed M. Abdel-Azeem. “Fungal Lipases: Insights into Molecular Structures and Biotechnological Applications in Medicine and Dairy Industry” Industrially Important Fungi for Sustainable Development, 461-514, Springer, Cham, (2021).

DOI: https://doi.org/10.1007/978-3-030-85603-8_13

——– 0
70.   Saied EM, El-Maradny YA, Osman AA, Darwish AMG, Abo Nahas HH, Niedbała G, Piekutowska M, Abdel-Rahman MA, Balbool BA, Abdel-Azeem AM. “A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19” Pharmaceutics, 13(11), 1759, (2021).

DOI: https://doi.org/10.3390/pharmaceutics13111759

6.321 28
71.   El Azab, Islam H., Essa M. Saied, Alaa A. Osman, Amir E. Mehana, Hosam A. Saad, and Nadia AA Elkanzi. “Novel N-bridged pyrazole-1-carbothioamides with potential antiproliferative activity: design, synthesis, in vitro and in silico studies” Future Medicinal Chemistry13(20), 1743-1766, (2021).

DOI: https://doi.org/10.4155/fmc-2021-0066

3.808 15
72.   Trabik, Yossra A., Eman M. Moenes, Medhat A. Al-Ghobashy, Marianne Nebsen, and Miriam F. Ayad. “Analytical comparability study of anti-CD20 monoclonal antibodies rituximab and obinutuzumab using a stability-indicating orthogonal testing protocol: Effect of structural optimization and glycoengineering.”, Journal of Chromatography B, 1159, 122359, (2020), ISSN 1570-0232.

DOI: https://doi.org/10.1016/j.jchromb.2020.122359.

1.911 2
73.   Mohamed, Hadeer G., Medhat A. Al‐Ghobashy, Mervat A. Fouad, and Hala S. Zaazaa. “Quality Assessment of Lactoferrin in some Marketed Nutraceuticals Derived from Milk using Validated Analytical Methods.”, ChemistrySelect, 5(46), 14816-14825, (2020).

DOI: https://doi.org/10.1002/slct.202003681.

2.109 1
74.   Nadia G. Zaki, Walaa H. Mahmoud, Ahmed M. El Kerdawy, Abanoub Abdullah, Gehad G. Mohamed. “Structural Characterization, Thermal Analyses, Antiproliferative and Antimicrobial Activity of Cocaine Complexes with Mn(II) and Cu(II)”, Egyptian Journal of Chemistry, 63(5), 1857-1868, (2020).

DOI: 10.21608/ejchem.2019.16748.2019.

0.966 5
75.   Nadia G. Zaki, Walaa H. Mahmoud, Ahmed M. El Kerdawy, Abanoub Mosaad Abdallah, Gehad G. Mohamed. “Heteroleptic complexes of cocaine/TMEDA with some f block metals: Synthesis, DFT studies, spectral, thermal, cytotoxicity and antimetastatic properties”, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 229, 117938, (2020), ISSN 1386-1425.

DOI: https://doi.org/10.1016/j.saa.2019.117938.

3.232 11
76.   Ehab M. Gedawy, Asmaa E. Kassab, Ahmed M. El Kerdawy. “Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors”, European Journal of Medicinal Chemistry, 189, 112066, (2020), ISSN 0223-5234.

DOI: https://doi.org/10.1016/j.ejmech.2020.112066.

5.573 43
77.   Heba T. Abdel-Mohsen, Ahmed M. El Kerdawy, Mohamed A. Omar, Emanuela Berrino, Ahmed S. Abdelsamie, Hoda I. El Diwani, Claudiu T. Supuran. “New thiopyrimidine-benzenesulfonamide conjugates as selective carbonic anhydrase II inhibitors: synthesis, in vitro biological evaluation, and molecular docking studies”, Bioorganic & Medicinal Chemistry, 28(5), 115329, (2020), ISSN 0968-0896.

DOI: https://doi.org/10.1016/j.bmc.2020.115329.

3.073 14
78.   Zaki, N.G., Mahmoud, W.H., El Kerdawy, A.M. et al. “Structural characterization, thermal, DFT, cytotoxicity, and antimetastatic properties of cocaine complexes with La(III), Er(III), and Yb(III)”, Res Chem Intermed, 46, 3193–3216, (2020).

DOI: https://doi.org/10.1007/s11164-020-04146-3.

2.262 7
79.   Abdel-Mohsen HT, Abd El-Meguid EA, El Kerdawy AM, Mahmoud AEE, Ali MM. “Design, synthesis, and molecular docking of novel 2-arylbenzothiazole multiangiokinase inhibitors targeting breast cancer”, Arch Pharm (Weinheim), 353(4), e1900340, (2020).

DOI:  10.1002/ardp.201900340.

2.590 15
80.   Heba Abdelrasheed Allam, Enayat E. Aly, Ahmed K.B.A.W. Farouk, Ahmed M. El Kerdawy, Essam Rashwan, Safinaz E.S. Abbass. “Design and Synthesis of some new 2,4,6-trisubstituted quinazoline EGFR inhibitors as targeted anticancer agents”, Bioorganic Chemistry, 98, 103726, (2020), ISSN 0045-2068.

DOI: https://doi.org/10.1016/j.bioorg.2020.103726.

4.831 29
81.   Riham F. George, Manal Kandeel, Dina Y. El-Ansary, Ahmed M. El Kerdawy. “Some 1,3,5-trisubstituted pyrazoline derivatives targeting breast cancer: Design, synthesis, cytotoxic activity, EGFR inhibition and molecular docking”, Bioorganic Chemistry99, 103780, (2020), ISSN 0045-2068.

DOI: https://doi.org/10.1016/j.bioorg.2020.103780.

4.831 13
82.   Abdel-Mohsen HT, Abdullaziz MA, El Kerdawy AM, Ragab FAF, Flanagan KJ, Mahmoud AEE, Ali MM, El Diwani HI, Senge MO. “Targeting Receptor Tyrosine Kinase VEGFR-2 in Hepatocellular Cancer: Rational Design, Synthesis and Biological Evaluation of 1,2-Disubstituted Benzimidazoles”, Molecules, 25(4), 770, (2020).

DOI: https://doi.org/10.3390/molecules25040770.

3.267 19
83.   Mohammad M. Al-Sanea, Ahmed Elkamhawy, Sora Paik, Kyeong Lee, Ahmed M. El Kerdawy, Bukhari Syed Nasir Abbas, Eun Joo Roh, Wagdy M. Eldehna, Heba A.H. Elshemy, Rania B Bakr, Ibrahim Ali Farahat, Abdulaziz I. Alzarea, Sami I. Alzarea, Khalid S. Alharbi, Mohamed A. Abdelgawad. “Sulfonamide-based 4-anilinoquinoline derivatives as novel dual Aurora kinase (AURKA/B) inhibitors: Synthesis, biological evaluation and in silico insights”, Bioorganic & Medicinal Chemistry, 28(13), 115525, (2020), ISSN 0968-0896.

DOI: https://doi.org/10.1016/j.bmc.2020.115525.

3.073 25
84.   Al-Warhi T, El Kerdawy AM, Aljaeed N, Ismael OE, Ayyad RR, Eldehna WM, Abdel-Aziz HA, Al-Ansary GH. “Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole–Indole Conjugates as Anticancer CDK Inhibitors”, Molecules, 25(9), 2031, (2020).

DOI: https://doi.org/10.3390/molecules25092031.

3.267 22
85.   Osman SM, Ayoub NA, Hafez SA, Ibrahim HA, El Raey MA, El-Emam SZ, Seada AA, Saadeldeen AM. “Aldose reductase inhibitor form Cassia glauca: A comparative study of cytotoxic activity with Ag nanoparticles (NPs) and molecular docking evaluation”, PLoS ONE, 15(10), e0240856, (2020).

DOI: https://doi.org/10.1371/journal.pone.0240856.

3.240 2
86.   Shendy, A.H., Eltanany, B.M., Al-Ghobashy, M.Aet al. “Coupling of GC-MS/MS to Principal Component Analysis for Assessment of Matrix Effect: Efficient Determination of Ultra-Low Levels of Pesticide Residues in Some Functional Foods”, Food Anal. Methods12, 2870–2885, (2019).

DOI: https://doi.org/10.1007/s12161-019-01643-z.

3.366 7
87.   El-Sayed, Ghada M., Medhat A. Al-Ghobashy, Ali K. Attia, and Samah M. Kamal. “Nanoparticle-Enhanced Potentiometric Ion-Selective Electrodes for Therapeutic Drug Monitoring of Linezolid.”, Journal of The Electrochemical Society, 166 (14), 1-9, (2019).

DOI:  10.1149/2.1221913jes.

4.316 6
88.   Hassan LA, Al-Ghobashy MA, Abbas SS. “Evaluation of the pattern and kinetics of degradation of adalimumab using a stability-indicating orthogonal testing protocol”, Biomed Chromatogr., 33(12), e4676, (2019).

DOI:  10.1002/bmc.4676.

1.902 3
89.   Al-Ghobashy MA, Nadim AH, El-Sayed GM, Nebsen M. “Label-Free Potentiometric Ion Flux Immunosensor for Determination of Recombinant Human Myelin Basic Protein: Application to Downstream Purification from Transgenic Milk”, ACS Sens., 4(2), 413-420, (2019).

DOI:  10.1021/acssensors.8b01315.

7.711 10
90.   Hassan, Lamiaa A., Sara M Shatat, Basma M Eltanany, Medhat A Al-Ghobashy, and Samah S Abbas. “Stability and biosimilarity assessment of infliximab using an orthogonal testing protocol and statistically-guided interpretation of peptide mapping”, Analytical methods, 11 (25), 3198-3211, (2019). DOI: 10.1039/c9ay00903e. 2.896 9
91.   Ibrahim, F.A., Al-Ghobashy, M.A. & Abo-Elmagd, I.F. “Energy-efficient carbon-doped titanium dioxide nanoparticles: synthesis, characterization, and catalytic properties under visible LED irradiation for degradation of Gemifloxacin”, SN Appl. Sci., 1, 631, (2019).

 DOI: 10.1007/s42452-019-0644-8

———- 2
92.   Iman A.Y. Ghannam, Eman A. Abd El-Meguid, Islam H. Ali, Donia H. Sheir, Ahmed M. El Kerdawy. “Novel 2-arylbenzothiazole DNA gyrase inhibitors: Synthesis, antimicrobial evaluation, QSAR and molecular docking studies”, Bioorganic Chemistry, 93, 103373, (2019).  DOI: 10.1016/j.bioorg.2019.103373. 3.926 14
93.   Heba T. Abdel-Mohsen, Mohamed A. Omar, Ahmed M. El Kerdawy, Abeer E.E. Mahmoud, Mamdouh M. Ali, Hoda I. El Diwani. “Novel potent substituted 4-amino-2-thiopyrimidines as dual VEGFR-2 and BRAF kinase inhibitors”, European Journal of Medicinal Chemistry, 179, 707-722, (2019), ISSN 0223-5234.

 DOI: 10.1016/j.ejmech.2019.06.063.

5.573 26
94.   Somaia S. Abd El-Karim, Yasmin M. Syam, Ahmed M. El Kerdawy, Tamer M. Abdelghany. “New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies”, Bioorganic Chemistry, 86, 80-96, (2019), ISSN 0045-2068.

 DOI: 10.1016/j.bioorg.2019.01.026.

3.926 40
95.   Wagdy M. Eldehna, Ahmed M. El Kerdawy, Ghada H. Al-Ansary, Sara T. Al-Rashood, Mamdouh M. Ali, Abeer E. Mahmoud. “Type IIA – Type IIB protein tyrosine kinase inhibitors hybridization as an efficient approach for potent multikinase inhibitor development: Design, synthesis, anti-proliferative activity, multikinase inhibitory activity and molecular modeling of novel indolinone-based ureides and amides”, European Journal of Medicinal Chemistry, 163, 37-53, (2019), ISSN 0223-5234.

 DOI: 10.1016/j.ejmech.2018.11.061.

5.573 41
96.   El Kerdawy, A.M., Osman, A.A. & Zaater, M.A. “Receptor-based pharmacophore modeling, virtual screening, and molecular docking studies for the discovery of novel GSK-3β inhibitors”, J Mol Model, 25(6), 171, (2019).

 DOI: 10.1007/s00894-019-4032-5.

1.346 18
97.   Attallah, O.A., Al-Ghobashy, M.A., Nebsen, M. et al. “Assessment of pectin-coated magnetite nanoparticles in low-energy water desalination applications”, Environ Sci Pollut Res25, 18476–18483 (2018).

DOI: 10.1007/s11356-018-2060-9.

4.223 7
98.   Medhat A. Al-Ghobashy, Samah M. Kamal, Ghada M. El-Sayed, Ali K. Attia, Mohamed Nagy, Ahmed ElZeiny, Marwa T. Elrakaiby, Mohammed M. Nooh, Maggie Abbassi, Ramy K. Aziz. “Determination of voriconazole and co-administered drugs in plasma of pediatric cancer patients using UPLC-MS/MS: A key step towards personalized therapeutics”, Journal of Chromatography B, 1092, 489-498, (2018), ISSN 1570-0232.

 DOI: 10.1016/j.jchromb.2018.06.043

1.911 5
99.   Olivia A. Attallah, Medhat A. Al-Ghobashy, Ahmed Taha Ayoub, Marianne Nebsen. “Magnetic molecularly imprinted polymer nanoparticles for simultaneous extraction and determination of 6-mercaptopurine and its active metabolite thioguanine in human plasma”, Journal of Chromatography A, 1561, 28-38, (2018), ISSN 0021-9673.

 DOI: 10.1016/j.chroma.2018.05.038

4.759 28
100.   Attallah OA, Al-Ghobashy MA, Ayoub AT, Tuszynski JA, Nebsen M. “Computer-aided design of magnetic molecularly imprinted polymer nanoparticles for solid-phase extraction and determination of levetiracetam in human plasma”, Rsc Advances, 8(26), 14280-92, (2018).  DOI: 10.1039/C8RA02379D. 3.361 11
101.   Ali K. Attia, Medhat A. Al-Ghobashy, Ghada M. El-Sayed, Samah M. Kamal. “Voltammetric monitoring of linezolid, meropenem and theophylline in plasma”, Analytical Biochemistry, 545, 54-64, (2018), ISSN 0003-2697.

DOI:  10.1016/j.ab.2018.01.009.

3.365 11
102.   Hoda E. Mohamed, Abeer A. Mohamed, Medhat A. Al-Ghobashy, Faten A. Fathalla, Samah S. Abbas. “Stability assessment of antibody-drug conjugate Trastuzumab emtansine in comparison to parent monoclonal antibody using orthogonal testing protocol”, Journal of Pharmaceutical and Biomedical Analysis, 150, 268-277, (2018), ISSN 0731-7085.

 DOI: 10.1016/j.jpba.2017.12.022.

3.935 23
103.   Sara M. Shatat, Basma M. Eltanany, Abeer A. Mohamed, Medhat A. Al-Ghobashy, Faten A. Fathalla, Samah S. Abbas. “Coupling of on-column trypsin digestion–peptide mapping and principal component analysis for stability and biosimilarity assessment of recombinant human growth hormone”, Journal of Chromatography B, 1072, 105-115, (2018), ISSN 1570-0232.

 DOI: 10.1016/j.jchromb.2017.11.007

1.911 11
104.   Marwa A. Fouad, Enas H. Tolba, Manal A. El-Shal, Ahmed M. El Kerdawy. “QSRR modeling for the chromatographic retention behavior of some β-lactam antibiotics using forward and firefly variable selection algorithms coupled with multiple linear regression”, Journal of Chromatography A, 1549, 51-62, (2018), ISSN 0021-9673.

 DOI: 10.1016/j.chroma.2018.03.042.

3.858 16
105.   Ibrahim, F.A., Al-Ghobashy, M.A., Abd El-Rahman, M.K. et al. “Optimization and in line potentiometric monitoring of enhanced photocatalytic degradation kinetics of Gemifloxacin using TiO2 nanoparticles/H2O2”. Environ Sci Pollut Res24, 23880–23892 (2017).

 DOI: 10.1007/s11356-017-0045-8.

4.223 10
106.   Heba S. Abed, Medhat A. Al-Ghobashy, Faten A. Fathalla, Maissa Y. Salem. “Evaluation of the combined effects of pegylation and glycosylation on the stability of erythropoietin using a stability-indicating SE-HPLC”, Biologicals, 50, 129-136, (2017), ISSN 1045-1056.

 DOI: 10.1016/j.biologicals.2017.08.012.

1.856 3
107.   Moenes, Eman M., Medhat A Al-Ghobashy, Abeer A Mohamed, and Maissa Y Salem. “Comparative Assessment of the Effect of Glyco-engineering on the Pattern and Kinetics of Aggregate Formation of Darbepoetin Alfa using a Stability-Indicating Orthogonal Testing Protocol”, Journal of Chromatography B1072, 405-414, (2017), ISSN 1570-0232. DOI: 10.1016/j.jchromb.2017.10.057. 1.911 6
108.   Khalifa M, Abdelsalam RM, Safar MM, Zaki HF. Phosphodiesterase (PDE) III inhibitor, Cilostazol, improved memory impairment in aluminum chloride-treated rats: modulation of cAMP/CREB pathway. Inflammopharmacology. (2022). Online ahead of print

DOI: 10.1007/s10787-022-01010-1.

5.093    0
109.   Saad MA, Eissa NM, Ahmed MA, ElMeshad AN, Laible G, Attia AS, Al-Ghobashy MA, Abdelsalam RM, Al-Shorbagy MY. Nanoformulated Recombinant Human Myelin Basic Protein and Rituximab Modulate Neuronal Perturbations in Experimental Autoimmune Encephalomyelitis in Mice. Int J Nanomedicine. 7;17:3967-3987.(2022) DOI:10.1016/j.biopha.2021.111494. 7.033 0
110.   Hussien YA, Mansour DF, Nada SA, Abd El-Rahman SS, Abdelsalam RM, Attia AS, El-Tanbouly DM. Linagliptin attenuates thioacetamide-induced hepatic encephalopathy in rats: Modulation of C/EBP-β and CX3CL1/Fractalkine, neuro-inflammation, oxidative stress and behavioral defects. Life Sci., 15;295:120378.(2022)

DOI: 10.1016/j.lfs.2022.120378

6.780            1
111.   El-Safty H, Ismail A, Abdelsalam RM, El-Sahar AE, Saad MA. Dapagliflozin diminishes memory and cognition impairment in Streptozotocin induced diabetes through its effect on Wnt/β-Catenin and CREB pathway. Brain Res Bull.,181:109-120 (2022)

DOI: 10.1016/j.brainresbull.2022.01.017.

3.715           2
112.   El-Shamarka ME, El-Sahar AE, Saad MA, Assaf N, Sayed RH. Inosine attenuates 3-nitropropionic acid-induced Huntington’s disease-like symptoms in rats via the activation of the A2AR/BDNF/TrKB/ERK/CREB signaling pathway. Life Sci. 2022, 1;300:120569.(2022)

DOI: 10.1016/j.lfs.2022.120569.

6.780            3
113.   El-Ghannam MS, Saad MA, Nassar NN, El-Yamany MF, El-Bahy AAZ. Linagliptin ameliorates acetic acid-induced colitis via modulating AMPK/SIRT1/PGC-1α and JAK2/STAT3 signaling pathway in rats. Toxicol Appl Pharmacol., 1;438:115906. (2022)

DOI: 10.1016/j.taap.2022.115906

4.460 3
114.   Saad MA, Al-Shorbagy MY, Arab HH. Targeting the TLR4/NF-κΒ Axis and NLRP1/3 Inflammasomes by Rosuvastatin: A Role in Impeding Ovariectomy-Induced Cognitive Decline Neuropathology in Rats. Mol Neurobiol., 59(7):4562-4577(2022).

DOI: 10.1007/s12035-022-02852-0.

5.686           1
115.   Al-Madhagy SA, Gad SS, Mostafa ES, Angeloni S, Saad MA, Sabry OM, Caprioli G, El-Hawary SS. A new arsenal of polyphenols to make Parkinson’s disease extinct: HPLC-MS/MS profiling, very interesting MAO-B inhibitory activity and antioxidant activity of Otostegia fruticosa. Nat Prod Res., 22:1-6.(2022)

DOI: 10.1080/14786419.2022.204481

2.488 1
116.   Amina A Gamal El Din , Khaled Mahmoud , Rabab H Sayed , Yousreya A Maklad, Ayman E El-Sahar. Vitamin D ameliorates diethylnitrosamine-induced liver preneoplasia: A pivotal role of CYP3A4/CYP2E1 via DPP-4 enzyme inhibition. Toxicol Appl Pharmacol. 1;458:116324. (2022)

DOI: 10.1016/j.taap.2022.116324

4.219              0
117.   Elsebaie MM, Nour El-Din HT, Abutaleb NS, Abuelkhir AA, Liang HW, Attia AS, Seleem MN, Mayhoub AS. Exploring the structure-activity relationships of diphenylurea as an antibacterial scaffold active against methicillin- and vancomycin-resistant Staphylococcus aureus. Eur J Med Chem., 15;234:114204 (2022).

DOI: 10.1016/j.ejmech.2022.114204.

7.088 3
118.   Nour El-Din HT, Elsebaie MMn   Abutaleb NS, Kotb AM, Attia AS,  Seleem MN, Mayhoub AS. Expanding the Structure-Activity Relationships of Alkynyl Diphenylurea Scaffold as Promising Antibacterial Agents. RSC Med. Chem., Online ahead of print (2022).  DOI:org/10.1039/D2MD00351A 3.470 0
119.   Ibrahim S, Fahim SA, Tadros SA, Badary OA. Suppressive effects of thymoquinone on the initiation stage of diethylnitrosamine hepatocarcinogenesis in rats. IJ Biochem Mol Toxicol. Aug;36(8):e23078. (2022)

DOI: 10.1002/jbt.23078

3.642 2
120.   Motawi TMK, Sadik NAH, Sabry D, Fahim SA, Shahin NN.rs62139665 olymorphism in the Promoter Region of EpCAM Is Associated With Hepatitis C Virus-Related Hepatocellular Carcinoma Risk in Egyptians. Front Oncol. 5;11:754104. (2022)

DOI: 10.3389/fonc.2021.754104.

6.24 0
121.   Amul M. Badr, Omayma Elkholy, Mona Said, Sally A. Fahim, Mohamed El-Khatib, Dina Sabry, Radwa M. Gaber. Diagnostic significance of hsa_circ_0000146 and hsa_circ_0000072 biomarkers for diabetic kidney disease in patients with type 2 diabetes mellitus. J Med Biochem. 42: 1–10, 2023.(2022)

DOI: 10.5937/jomb0-39361.

2.20 0
122.   Tadros SA, Attia YM, Maurice NW, Fahim SA, Abdelwahed FM, Ibrahim S, Badary OA. Thymoquinone Suppresses Angiogenesis in DEN-Induced Hepatocellular Carcinoma by Targeting miR-1-3p. Int J Mol Sci., Dec 14;23(24):15904. (2022)

DOI: 10.3390/ijms232415904.

6.20 0
123.   Showman, Maha M., Rania M. Abdelsalam, Mahmoud M. Tawfick, Sanaa A. Kenawy, and Mona M. El-Naa. “Antisense Tissue Factor Oligodeoxynucleotides Protected Diethyl Nitrosamine/Carbon Tetrachloride-Induced Liver Fibrosis Through Toll Like Receptor4-Tissue Factor-Protease Activated Receptor1 Pathway.”, Frontiers in Pharmacology, 12, 1140, (2021), ISSN 1663-9812.

https://doi.org/10.3389/fphar.2021.676608.

3.845 0
124.   Hagar B. Abo-Zalam , Ezzeldein S. El-Denshary, Rania M. Abdelsalam, Islam A. Khalil, Mahmoud M. Khattab, and Mohamed A. Hamzawy. “Therapeutic advancement of simvastatin-loaded solid lipid nanoparticles (SV-SLNs) in treatment of hyperlipidemia and attenuating hepatotoxicity, myopathy and apoptosis: Comprehensive study.”, Biomedicine & Pharmacotherapy, 139, 111494, (2021). https://doi.org/10.1016/j.biopha.2021.111494. 4.545 3
125.   Hagar B. Abo-Zalam , Rania M. Abdelsalam, Rehab F. Abdel-Rahman, Mohamed F. Abd-Ellah, Mahmoud M. Khattab “In Vivo Investigation of the Ameliorating Effect of Tempol against MIA-Induced Knee Osteoarthritis in Rats: Involvement of TGF-β1/SMAD3/NOX4 Cue.” Molecules. 19;26(22):6993 (2021), ISSN: 1420-3049. https://doi.org/10.3390/molecules26226993. 4.411 3
126.   Radwa N. MuhammadLamiaa A. AhmedRania M. AbdelSalamKawkab A. AhmedAmina S. Attia. “Crosstalk Among NLRP3 Inflammasome, ET B R Signaling, and miRNAs in Stress-Induced Depression-Like Behavior: a Modulatory Role for SGLT2 Inhibitors.” Neurotherapeutics. Online ahead of print (2021). ISSN: 1933-7213 (print); 1878-7479 (web).

https://doi.org/10.1007/s13311-021-01140-4.

7.620 11
127.   Amer MA, Wasfi R, Attia AS, Ramadan MA. “Indole Derivatives Obtained from Egyptian Enterobacter sp. Soil Isolates Exhibit Antivirulence Activities against Uropathogenic Proteus mirabilis”,  Antibiotics, 10(4), 363, (2021). https://doi.org/10.3390/antibiotics10040363 3.893 5
128.   Elhosseiny, Noha M., Tamer M. Samir, Aliaa A. Ali, Amani A. El-Kholy, and Ahmed S. Attia. “Development of an Immunochromatographic Strip Using Conjugated Gold Nanoparticles for the Rapid Detection of Klebsiella pneumoniae  Causing Neonatal Sepsis” Pharmaceutics, 13(8), 1141, (2021).

https://doi.org/10.3390/pharmaceutics13081141.

6.321 0
129.   Samar M. Shawki, Mohammed A. Saad, Rania M. Rahmo, Walaa Wadie and Hanan S. El-Abhar, “Liraglutide Improves Cognitive and Neuronal Function in 3-NP Rat Model of Huntington’s Disease”, Frontiers in pharmacology, Epub. Ahead of print, (2021).

https://doi.org/10.3389/fphar.2021.731483.

5.811 5
130.   Soha Ramadan, Manal M. Sabry, Muhammed A Saad, Simone Angeloni, Omar M. Sabry, Giovanni Caprioli & Soheir M. El Zalabani “Dismantling Parkinson’s disease with herbs: MAO-B inhibitory activity and quantification of chemical constituents using HPLC-MS/MS of Egyptian local market plants”, Natural Product Research, Epub. Ahead of print, (2021).

https://doi.org/10.1080/14786419.2021.2013836.

2.862 2
131.                Muhammed A.Saad, Maha A.E. Ahmed, Norhan N.Elbadawy, Noha F.Abdelkader “Nano-ivabradine averts behavioral anomalies in Huntington’s disease rat model via modulating Rhes/m-tor pathway”,Progress in Neuro-Psychopharmacology and Biological Psychiatry, 111, (2021), 110368.

https://doi.org/10.1016/j.pnpbp.2021.110368.

5.067 4
132.                Rofida A. Saleh, Tarek F. Eissa, Dalaal M. Abdallah, Muhammed A. Saad, Hanan S. El- Abhar. “Peganum harmala enhanced GLP-1 and restored insulin signaling to alleviate AlCl3-induced Alzheimer-like pathology model.” Scientific reports, 11, 12040, (2021).

https://doi.org/10.1038/s41598-021-90545-4.

4.380 6
133.                Doaa Fathi, Ahmed I.Abulsoud, Muhammed A.Saad, Noha N.Nassar, Mina M.Maksimose, Sherine M.Rizk, Mahmoud A.Senousy “Agomelatine attenuates alcohol craving and withdrawal symptoms by modulating the Notch1 signaling pathway in rats”, Life Sciences, 284, (2021), 119904.

https://doi.org/10.1016/j.lfs.2021.119904.

5.037 4
134.                Amr M. Emam, Muhammad A. Saad, Naglaa A. Ahmed, Hala F. Zaki. “Vortioxetine mitigates neuronal damage by restricting PERK/eIF2α/ATF4/CHOP signaling pathway in rats subjected to focal cerebral ischemia-reperfusion”, Life Sciences, 283, 119865, (2021), ISSN 0024-3205.

https://doi.org/10.1016/j.lfs.2021.119865.

5.037 4
135.                El-Yamany, Muhammed F., Eman S. Zaki, Sherif A. Shaltout, and Muhammed A. Saad. “Bone marrow mononuclear cells boosts anti-cytogentical aberration effect of N-Acetylcysteine and α-lipoic acid in rat’s liver and bone marrow: Implication of oxidative and inflammatory pathways”, Toxicology Mechanisms and Methods, 1-13, (2021).

https://doi.org/10.1080/15376516.2021.1906370.

2.987 2
136.                Hany H. Arab, Muhammad Y. Al-Shorbagy, Muhammed A. Saad. “Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental inflammatory bowel disease in rats: Targeting AMPK/mTOR, HMGB1/RAGE and Nrf2/HO-1 pathways”, Chemico-Biological Interactions, 335, 109368, (2021), ISSN 0009-2797.

https://doi.org/10.1016/j.cbi.2021.109368.

5.194 40
137.                Motawi, Tarek Mohamed Kamal, Nermin Abdel Hamid Sadik, Dina Sabry, Sally Atef Fahim, and Nancy Nabil Shahin. “rs62139665 polymorphism in the promoter region of EpCAM is associated with hepatitis C virus-related hepatocellular carcinoma risk in Egyptians.” Frontiers in Oncology: 5476. (2021).

DOI: 10.3389/fonc.2021.754104

6.230 0
138.                Muhammed A. Saad, Muhammad A. Eltarzy, Rania M. Abdel Salam, Maha A.E. Ahmed. “Liraglutide mends cognitive impairment by averting Notch signaling pathway overexpression in a rat model of polycystic ovary syndrome”, Life Sciences, 265, 118731, (2021), ISSN 0024-3205.

htts://doi.org/10.1016/j.lfs.2020.118731.

5.037 6
139.                Saad, Muhammad AE, Mohamed IM Fahmy, Rabab H. Sayed, Muhammad F. El‐Yamany, Reham El‐Naggar , Ahmed AE Hegazy, and Muhammad Al‐Shorbagy. “Eprosartan: A closer insight into its neuroprotective activity in rats with focal cerebral ischemia–reperfusion injury.”, Journal of Biochemical and Molecular Toxicology, (2021). https://doi.org/10.1002/jbt.22796. 3.652 2
140.                Nour El-Din HT, Elhosseiny NM, El-Gendy MA, Mahmoud AA, Hussein MMM, Attia AS. “A Rapid Lysostaphin Production Approach and a Convenient Novel Lysostaphin Loaded Nano-emulgel; As a Sustainable Low-Cost Methicillin-Resistant Staphylococcus aureus Combating Platform”, Biomolecules. 10(3), 435, (2020). https://doi.org/10.3390/biom10030435 4.879 8
141.                Rasha R. Yossef, Mohamed F. Al-Yamany, Muhammed A. Saad, Ayman E. El-Sahar. “Neuroprotective effects of vildagliptin on drug induced Alzheimer’s disease in rats with metabolic syndrome: Role of hippocampal klotho and AKT signaling pathways”, European Journal of Pharmacology, 889, 173612, (2020), ISSN 0014-2999.

https://doi.org/10.1016/j.ejphar.2020.173612.

3.263 10
142.                Hadir Farouk, Muhammed A. Saad, Sawsan S. Mahmoud, Mohammed F. El-Yamany, Ola A. Sharaf, Rania F. Ahmed, Ezz E. El-Denshary. “Effect of (+) and (-) hydroxycitric acid sterio-isomers present in natural products in counteracting insulin resistance”, Egyptian Journal of Chemistry, 63(11), 4341-4354, (2020).

DOI: 10.21608/ejchem.2020.25054.2493.

0.966 0
143.                Ayman E. El-Sahar, Alyasaa A. Rastanawi, Muhammed F. El-Yamany, Muhammed A. Saad. “Dapagliflozin improves behavioral dysfunction of Huntington’s disease in rats via inhibiting apoptosis-related glycolysis”, Life Sciences, 257, 118076, (2020), ISSN 0024-3205. https://doi.org/10.1016/j.lfs.2020.118076. 3.647 18
144.                Hebatullah S. Helmy, Mahmoud A. Senousy, Ayman E. El-Sahar, Rabab H. Sayed, Muhammed A. Saad, Eman M. Elbaz. “Aberrations of miR-126-3p, miR-181a and sirtuin1 network mediate Di-(2-ethylhexyl) phthalate-induced testicular damage in rats: The protective role of hesperidin”, Toxicology, 433–434, 152406, (2020). https://doi.org/10.1016/j.tox.2020.152406. 4.099 19
145.                Hany H. Arab, Muhammed A. Saad, Ayman E. El-Sahar, Muhammad Y. Al-Shorbagy. “Mechanistic perspective of morin protection against ketoprofen-induced gastric mucosal injury: Targeting HMGB1/RAGE/NF-κB, DJ-1/Nrf2/HO-1 and PI3K/mTOR pathways”, Archives of Biochemistry and Biophysics, 693, 108552, (2020), ISSN 0003-9861. https://doi.org/10.1016/j.abb.2020.108552. 3.391 13
146.                Saad MAE, Fahmy MIM, Al-Shorbagy M, Assaf N, Hegazy AAE, El-Yamany MF. “Nateglinide Exerts Neuroprotective Effects via Downregulation of HIF-1α/TIM-3 Inflammatory Pathway and Promotion of Caveolin-1 Expression in the Rat’s Hippocampus Subjected to Focal Cerebral Ischemia/Reperfusion Injury”, Inflammation, 43(2), 401-416, (2020).

Doi: 10.1007/s10753-019-01154-3.

3.212 5
147.                Muhammed A. Saad, Ayman E. El-Sahhar, Hany H. Arab, Muhammad Y. Al-Shorbagy. “Nicorandil abates arthritic perturbations induced by complete Freund’s adjuvant in rats via conquering TLR4-MyD88-TRAF6 signaling pathway”, Life Sciences, 218, 284-291, (2019), ISSN 0024-3205.

https://doi.org/10.1016/j.lfs.2019.01.002

5.037 11
148.                Radwan, A., El-Lakkany, N. M., William, S., El-Feky, G. S., Al-Shorbagy, M. Y., Saleh, S., & Botros, S. A. “Novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection”, Parasites Vectors12(1), 304, (2019).

https://doi.org/10.1186/s13071-019-3563-z.

3.876 10
149.                Choucry, A.M., Al-Shorbagy, M.Y., Attia, A.S. et al. “Pharmacological Manipulation of Trk, p75NTR, and NGF Balance Restores Memory Deficit in Global Ischemia/Reperfusion Model in Rats”, J Mol Neurosci, 68(1), 78–90, (2019).

https://doi.org/10.1007/s12031-019-01284-1.

3.444 7
150.                Hassan NF, Nada SA, Hassan A, El-Ansary MR, Al-Shorbagy MY, Abdelsalam RM. “Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis”, Inflammation, 42(3), 1056-1070, (2019).

Doi: 10.1007/s10753-019-00967-6.

4.092 16
151.                Eman M. Elbaz, Hebatullah S. Helmy, Ayman E. El-Sahar, Muhammed A. Saad, Rabab H. Sayed. “Lercanidipine boosts the efficacy of mesenchymal stem cell therapy in 3-NP-induced Huntington’s disease model rats via modulation of the calcium/calcineurin/NFATc4 and Wnt/β-catenin signalling pathways”, Neurochemistry International, 131, 104548, (2019), ISSN 0197-0186. https://doi.org/10.1016/j.neuint.2019.104548. 3.881 8
152.                Noha Abdel-Rahman, Maha H. Sharawy, Nirmeen Megahed, Mohammed S. El-Awady. “Vitamin D3 abates BDL-induced cholestasis and fibrosis in rats via regulating Hedgehog pathway”, Toxicology and Applied Pharmacology, 380, 114697, (2019), ISSN 0041-008X. https://doi.org/10.1016/j.taap.2019.114697. 4.219 2
153.                Ibrahim, S.M., Al-Shorbagy, M.Y., Abdallah, D.M. et al. “Activation of α7 Nicotinic Acetylcholine Receptor Ameliorates Zymosan-Induced Acute Kidney Injury in BALB/c Mice”, Sci Rep8(1), 16814, (2018). https://doi.org/10.1038/s41598-018-35254-1. 4.380 15
154.                Rabab M. Ali, Muhammad Y. Al-Shorbagy, Maged W. Helmy, Hanan S. El-Abhar. “Role of Wnt4/β-catenin, Ang II/TGFβ, ACE2, NF-κB, and IL-18 in attenuating renal ischemia/reperfusion-induced injury in rats treated with Vit D and pioglitazone”, European Journal of Pharmacology, 15(831), 68-76, (2018), ISSN 0014-2999.

https://doi.org/10.1016/j.ejphar.2018.04.032.

4.432 24
155.                Mohammed K. AbdElhameid, Madlen B. Labib, Ahmed T. Negmeldin, Muhammad Al-Shorbagy & Manal R. Mohammed, “Design, synthesis, and screening of ortho-amino thiophene carboxamide derivatives on hepatocellular carcinomaas VEGFR-2Inhibitors”, Journal of Enzyme Inhibition and Medicinal Chemistry33(1), 1472-1493, (2018).

DOI: 10.1080/14756366.2018.1503654.

5.051 11
156.                Abd Elhameid MK, Ryad N, Al-Shorbagy MY, Mohammed MR, Ismail MM, El Meligie S. “Design, Synthesis and Screening of 4,6-Diaryl Pyridine and Pyrimidine Derivatives as Potential Cytotoxic Molecules”, Chem Pharm Bull, 66(10), 939-952. (2018).

Doi: 10.1248/cpb.c18-00269.

1.645 5
157.                Mai El Halawany, Randa Latif and Mohamed H. H. AbouGhaly. Hemostatic Alginate/Nano‐Hydroxyapatite Composite Aerogel Loaded with Tranexamic Acid or the Potential Protection against Alveolar Osteitis. Pharmaceutics,14(10), 2255 (2022)

DOI: 10.3390/pharmaceutics14102255

6.525 0
158.                Hammad RW, Sanad RA, Abdelmalak NS, Latif R. Architecting novel multilayer nanosponges for co-administration of two drugs managing high-risk type II diabetes mellitus patients suffering from cardiovascular diseases. Int J Biol Macromol. 1;220:1429-1443 (2022)

DOI: 10.1016/j.ijbiomac.2022.09.099

8.025               0
159.                Farag MM, Louis MM, Badawy AA, NessemDI, Abdelmalak NS. Drotaverine Hydrochloride Superporous Hydrogel Hybrid System: a Gastroretentive Approach for Sustained Drug Delivery and Enhanced Viscoelasticity. AAPS PharmSciTech, 23:124 (2022)

DOI: org/10.1208/s12249-022-02280-2

3.45 0
160.                Rodayna Atef Shalaby, Omaima El-Gazayerly, Mohammed Abdallah.  Cubosomal Betamethasone-Salicylic Acid Nano Drug Delivery System for Enhanced Management of Scalp Psoriasis. Int J Nanomedicine. 13;17:1659-1677 (2022).

DOI: 10.2147/IJN.S345430.

7.033 2
161.                Abdelmonem R, Elhabal SF, Abdelmalak NS, El-Nabarawi MA, Teaima MH. “Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study.”, Pharmaceutics, 13(2), 221, (2021).

https://doi.org/10.3390/pharmaceutics13020221.

6.321 5
162.                Nageeb El-Helaly, S.; Abd-Elrasheed, E.; Salim, S.A.; Fahmy, R.H.; Salah, S.; EL-Ashmoony, M.M. “Green Nanotechnology in the Formulation of a Novel Solid Dispersed Multilayered Core-Sheath Raloxifene-Loaded Nanofibrous Buccal Film; In Vitro and In Vivo Characterization”, Pharmaceutics, 13, 474, (2021).

https://doi.org/10.3390/pharmaceutics13040474.

6.321 3
163.                Tawfik, M.A., Mohamed, M.I., Tadros, M.I., El-Helaly S.N. “Low-Frequency Sonophoresis as an Active Approach to Potentiate the Transdermal Delivery of Agomelatine-Loaded Novasomes: Design, Optimization, and Pharmacokinetic Profiling in Rabbits.” AAPS PharmSciTech 22, 261 (2021).

https://doi.org/10.1208/s12249-021-02147-y

3.246 1
164.                Marwa Eid Sayyed, Mohamed AbdEl-Motaleb, Ismail Taha Ibrahim, Hassan Medhat Rashed, Mohamed Ahmed El-Nabarawi, Mohamed Abdallah Ahmed. “Preparation, characterization, and in vivo biodistribution study of intranasal 131I-clonazepam-loaded phospholipid magnesome as a promising brain delivery system: Biodistribution and pharmacokinetic behavior of intranasal 131I-Clonazepam loaded phospholipid magnesome as a potential brain targeting system”, European Journal of Pharmaceutical Sciences, 169, 106089, (2021).

https://doi.org/10.1016/j.ejps.2021.106089

4.384 1
165.                Mohamed Abdallah Ahmed, Wedian Younis Abdelgawad, Mary Kamal Gad, Magdy Ibrahim Mohamed. “A novel approach for the treatment of oral ulcerative lesion using mucoadhesive proniosome gel”, Journal of Drug Delivery Science and Technology, 102460, (2021), ISSN 1773-2247.

https://doi.org/10.1016/j.jddst.2021.102460.

2.734 1
166.                A. Ramadan, E.B. Basalious and M. Abdallah. “Industrial application of QbD and NIR chemometric models in quality improvement of immediate release tablets”, Saudi Pharmaceutical Journal, (2021), ISSN 1319-0164. https://doi.org/10.1016/j.jsps.2021.04.012. 2.879 2
167.                Farag MM, Abd El Malak NS, Yehia SA, Ahmed MA. “Hyaluronic Acid Conjugated Metformin-Phospholipid Sonocomplex: A Biphasic Complexation Approach to Correct Hypoxic Tumour Microenvironment.”, Int J Nanomedicine., 16, 1005-1019, (2021).

Doi:10.2147/IJN.S297634

6.400 6
168.                Sandy N. Aziz, Alia A. Badawy, Demiana I. Nessem, Nevine S. Abd El Malak. “Promising nanoparticulate system for topical delivery of diphenhydramine hydrochloride: In-vitro and in-vivo evaluation”, Journal of Drug Delivery Science and Technology, 55, 101454, (2020). https://doi.org/10.1016/j.jddst.2019.101454 3.981 2
169.                Reham Waheed Hammad, Rania Abdel-Basset Sanad, Nevine Shawky Abdelmalak, Faisal A. Torad, Randa Latif. “New intranasal cross-linked mosapride xyloglucan pluronics micelles (MOS-XPMs) for reflux esophagitis disease: In-vitro optimization and improved therapeutic efficacy”, Journal of Advanced Research, 23, 83-94, (2020). https://doi.org/10.1016/j.jare.2020.01.013. 10.479 5
170.                Farag, Michael M., Nevine S. Abd El Malak, Soad A. Yehia, and Mohammed A. Ahmed. “Sonocomplexation as an effective tool to enhance the antitumorigenic effect of metformin: Preparation, in vitro characterization, molecular dynamic simulation & MiaPaCa-2 cell line hypoxia evaluation.”, Journal of Drug Delivery Science and Technology59, 101968, (2020), ISSN 1773-2247.

https://doi.org/10.1016/j.jddst.2020.101968.

3.981 3
171.                Louis, Mina M., Alia A. Badawy, Demiana I. Nessem, and Nevine S. Abd Elmalak. “Drotaverine hydrochloride gastroretentive floating mini-tablets: Formulation, in-vitro and in-vivo evaluation.”, Journal of Drug Delivery Science and Technology, 57, 101733, (2020), ISSN 1773-2247. https://doi.org/10.1016/j.jddst.2020.101733 3.981 7
172.                Omar NE, El-Fass KA, Abushouk AI, Elbaghdady N, Barakat AEM, Noreldin AE, Johar D, Yassin M, Hamad A, Elazzazy S, Dermime S. “Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review”, Front Immunol., 11, 1354, (2020). Doi: 10.3389/fimmu.2020.01354. 5.085 2

The School of Pharmacy academic calendar 2023-2024

Academic Calendar for Health Sciences Schools 2023-2024

 

1- Session Name: Inspiring insights shaping the future of pharmacy education and research

     presented by: Prof.Manal Maher

     Session Date: 30 November 2023

     Read the full story here.

 

 2-Session Name: ‘How to Know Your Personality Strength and Use it Properly in the               Workplace

     presented by: Mirna Masoud

     Session Date: 20 November 2023

Read the full story here.

 

3- Session Name: ‘Preventing Antimicrobial Resistance Together’

       presented by: Dr.Abeer El Behairy

       Session Date: 27 November 2023

Read the full story here.

 

4-Session Name: The Evolution of Green Pharmacy

    presented by: Prof.Osama Ibrahim

    Session Date: 23 October 2023.

    Read the full story here.

 

5- Session Name: Antibiotics use; Myths & Facts. 

      presented by: Dr.Nouran Hisham

      Session Date: 3 of October 2023.
Read the full story here.

6- Session Name: Climate Change and Global Health-Preparedness and Response.

     presented by: Dr.Radwa Ewaisha.

     Session Date: 2 of October 2023.
     Read the full story here.

 

7- Top Achievers Ceremony

      Date:21 Sep 2023.
      Read the full story here.



8- Roche Interview

     Date: 25 June 2023.
     Read the full story here.

 

9- SOP Conference

    Date: 21,22 June 2023
   Read the full story here.

 

10- PHAR501 Final Presentation

     Date: 25 of May 2023
     Read the full story here.

11- Accsight -MOU

    MOU Date: 29 March 2023
    Read the full story here.

12- Session Name:  Accelerate your Science Research and Education with Journal of      Visualized Experiment

   presented by: Dr.Passant Emad who is a Curriculum specialist ,JoVE

   Session Date: 1 February 2023

   Read the full story here.

 

13-Session Name: World’s water day.

      presented by: Dr.Radwa Ewaisha.

     Session Date: 13 of March 2023

     Read the full story here.

 

14-International Publication in 2022.

      Date: 25 of Jan 2023

      Read the full story here.

 

15-PHAR501 Final Presentation

      Date: 22 of January 2023.

     Read the full story here.

 

16- Session Name:  sustainability in universities ranking Session.

      presented by: Mai Rashad

     Session Date: 4 of January 2023

    Read the full story here.

 

17- New year Ceremony

      Date: 27 of December 2022.

     Read the full story here.

 

18- Session Name:  Is the Pandemic Over? -Covid19 Update.

      presented by: Dr. Radwa Ewaisha.

      Session Date: 22 of December 2022.

      Read the full story here.

 

19- Session Name:  Multiple Sclerosis session in collaboration with Pantomath

      presented by: Dr. Rehab Shammah.

      Session Date: 12 of December 2022.

      Read the full story here.

 

20- RAY -MOU

      MOU date: 7 December 2022.

      Read the full story here.

 

21-Liptis -MOU

     MOU date: 14 of November 2022

     Read the full story here.

 

22- Session Name:  Digital Health Session

     presented by: Dr.Heba Ali.

     Session Date: 26 of October 2022.

     Read the full story here.

 

23-Pharmacotherapy course.

      Date: 25 of October 2022

      Read the full story here.

 

24- SOP Top Achievers

       Date: 9 of October 2022

      Read the full story here.

 

25- Session Name:  Climate Change.

      presented by: Dr.Radwa Ewaisha.

      Session Date: 21 of September 2022

      Read the full story here.

 

26- L’Oréal Egypt MOU.

       MOU date: 24 July 2022.

      Read the full story here.

 

  •  Annual Winter Fair
  • visit to 57357 Hospital
  • outstanding performance of the non-academic staff for the Academic Year 2022-2023
  • the Future of Healthcare IT
  • Breast Cancer Awareness
  • Workshop: Accelerate your science research and education with Journal of visualized experiment

  • Awareness talk: Rationing Water Use

  • Awareness campaign: Role of vitamins in nutrition

   

  • Awareness campaign: Maternal health

 

  • Awareness campaign: Endemics in Egypt

  • Awareness campaign: Adolescence Mental Health

  • Awareness talk: How to use the Excel?

  • Training course: First Aids

  • International Publications Awards Ceremony

  • Staff Farewell celebration for the academic year 2022-2023

  • Annual Ramadan Night and Iftar

 

  • 57357 Hospital Visit

 

  • International Day for the Elimination of Violence Against Women – Hospice Egypt

 

  • Convoy to Beni-Suef

 

  • International Women’s Day- Hospice Egypt

 

  • Taaer Al Ganna Orphanage for disabled children

  • Campaign: RAMADAN Boxes
  • Charity exhibition: Charitable clothing exhibition for college employees

 

 

At SOP-NGU, we are committed to promoting sustainability in all aspects of education and research. As part of our dedication to a greener future, we recognize the importance of incorporating sustainability principles into the field of pharmacy. Our innovative approach to green pharmacy focuses on minimizing environmental impact while optimizing patient care. By integrating sustainable practices into pharmaceutical research, production, and distribution, we aim to reduce waste, conserve energy, and mitigate the ecological footprint of the healthcare industry. Through collaborative efforts with students, faculty, and community partners, we strive to shape the next generation of pharmacists who are not only knowledgeable in their field but also equipped with the tools to contribute to a healthier planet.

Why Sustainability in Pharmacy Matters

Pharmacies are at the heart of healthcare delivery, and they have a unique opportunity to lead the way in sustainable practices. By adopting green initiatives, pharmacies can:

  • Reduce Environmental Impact: By minimizing waste, conserving resources, and using eco-friendly materials, pharmacies can significantly decrease their environmental footprint.
  • Promote Public Health: Sustainable practices can positively impact public health by reducing exposure to harmful chemicals and pollutants.
  • Engage the Community: Implementing sustainable practices can create a positive image for your pharmacy and foster community engagement.
  • Stay Ahead of Regulatory Changes: Governments and regulatory bodies are increasingly focusing on sustainability. Adapting early can keep your pharmacy ahead of compliance requirements.Resources– United Nations Sustainable development goals Click here– Sustainability practices at WHO Click here– Environmentally sustainable health systems: a strategic document Click here

    – Sustainability in Pharmacy (FIP development goals) Click here

    –  Sustainability in Health care: The role of pharmacist and pharmacy practice Click here

    Activities

    – Climate Action Club Session
    Read Full story here 

    – Help Solve the Water Crisis
    Read Full story here

    – Climate Change and Global Health-Preparedness and Response
    Read Full story here

    – Eco-friendly Pharmacy Practice
    Read Full story here 

    Projects

    SOP will organize a campaign that facilitates the return of unused and expired medicines through a drug takeback initiative. Additionally, we are implementing efficient waste collection policies within pharmacy practices to ensure responsible handling of compounded medicines. Through collaboration with prescribers, we actively promote rational prescribing practices to minimize the occurrence of leftover medicines. Our aim is to create awareness and encourage responsible medication management for a safer and more sustainable healthcare system.

    Ecofriendly Team

    Our Ecofriendly Team is a group of passionate individuals dedicated to making a positive impact on the environment through sustainable practices. Comprised of students and staff members, we come together with a shared vision of creating a greener and more sustainable campus community. Through our collaborative efforts, we strive to implement eco-friendly initiatives and raise awareness about the importance of environmental conservation. From organizing recycling drives to promoting energy conservation, our team actively seeks innovative solutions to reduce our ecological footprint. Together, we inspire and empower others to adopt sustainable habits and make a difference in their daily lives.

    We encourage all members of the New Giza School of Pharmacy community to actively participate in our sustainability efforts and be part of the movement towards a more environmentally conscious future. Together, we can create a greener, more sustainable future for pharmacy practice.

     

    For inquiries or suggestions, please contact A.L Rodayna Atef: ratef@ngu.edu.eg

     

     

 

  • Roche Conference
  • The National Museum of Egyptian Civilization
  • EVA Cosmetics
  • Football tournament for girls
  • Charitable Padel tournament
  • Scientific trip: Vitabiotics UK and UCL visit
  • Informative talk: Data collection and monitoring
  • Informative talk: Introduction to Marketing Research
  • Informative talk: Medical Quires Handle Process
  • Informative talk: Sandoz Biosimilars
  • Workshop: Digital Health
  • Informative talk: Patient Journey Partner
  • Scientific event: Launching NGU Pharmaceutical Society
  • Workshop: CV writing and Interviewing skills
  • Campaign: Blood donation
  • Campaign: Fight the Fakes
  • Campaign: Multiple Sclerosis
  • Campaigns: CNS disorders
  • PHAR501: Experiential Research Module
  • Global Napi
  • Eva Cosmetics
  •  Marcyrl
  • Awareness talk: Is the pandemic over?
  • Cultural trip: Forever is Now exhibition
  • Freshmen Student’s Welcome Orientation
  • Top achievers’ ceremony for the AY2021/2022
  • Entertainment trip: Saint Catherine Mountain
  • International day of “Hospice”
  • International day for the “Elimination of violence against women” and Hospice Egypt
    Fundraising event
  • 57357 Voluntary Day
  • Third Convoy to Beni Suef
  • Year-2 visit to EL-Ezaby Pharmacy

 

  • NGU pharmaceutical society club (EPSF scientific annual conference)

 

  • Sandoz session- Soft skills

 

  • How to Pass an Interview? -Dr. Tarek Morsi

 

  • Radio Pharmacy Session-Dr Sherif Kamal

 

  • Year-3 CNS illness Leaflet Campaign

 

  • Year-3 visit to Liptis Pharmaceuticals

 

  • Global Napi Pharmaceutical visit-Year-3

 

  • Medical Queries handling process- Dr. Mirette Romany, Johnson & Johnson

 

  • Career discovery Session, Mariam Fouad-Sandoz

 

  • SOP top achievers Ceremony

 

  • EVA Talented Interns Graduation

 

 

 

 

SOP is unique in providing distinguished field training to all the students in all levels during the semester, in addition to summer training. SOP has prepared a specification for field training compatible with the educational programs’ competencies and learning outcomes of the modules.

The program aims to provide student interns with an overview of the current healthcare environment, expose them to current standards of care and policy driven pharmacy practice unique to hospitals and health-systems.

The school has concluded various memoranda of understanding, collaboration protocols and agreements with pharmaceutical companies, medical centers, and hospitals to provide student training in industrial pharmacy and clinical pharmacy. Example of these are the Armed Forces Medical Center in Maadi, Nassaem Hospital, Baheya Center for Early Detection and Treatment of Breast Cancer, International Medical Center, El-Moalmeen Hospital, Dar Al-Fouad Development Academy, Sandoz Egypt Co., L’Oréal Egypt Co., Magic Pharma/Vitabiotics Co., and Liptis Pharmaceuticals Co.

Upon successful completion of the requirements, the intern will receive a certificate of competence of the training.

Summer Internship

 

     Eva Internship


Global Napi Internship



Magic Pharma Internship.

 


Roche Conference Internship

 

This committee offers continuous interaction with students to permit maximum academic assistance to each student throughout his/her academic study. An academic advisor and a tutor are assigned to each group of students (5-10 students each) to observe their academic progress and offer support to each student. The goal of the advisory team in coordination with module leads and year leads is to remove any barriers that students may experience during their scholastic years. Moreover, struggling students receive more comprehensive assistance and close follow up to improve their educational performance.

The Quality Assurance Unit (QAU) of the School of Pharmacy-Newgiza University was established at the beginning of the AY2019/2020. QAU seeks to inculcate the culture of quality among all faculty members, including staff members, teaching assistants, admins, technicians, and students. The unit works to ensure the quality of the educational process, scientific research, and community participation, and to achieve the requirements of the labor market and align to the standards of the National Authority for Quality Assurance and Accreditation of Education (NAQAAE) to achieve institutional accreditation immediately after the graduation of the first batch of students. QAU operates through an approved and announced internal bylaw that includes all the competencies of the unit’s employees and its executive committees, and a guide to ensure the quality of achieving the standards of the National Authority for Quality Assurance and Accreditation of Education (NAQAAE).

  • QAU vision: The Quality Assurance Unit in the School of Pharmacy – Newgiza University seeks for the college to be nationally and internationally accredited.
  • QAU mission: The Quality Assurance Unit in the School of Pharmacy – Newgiza University aims to support a culture of quality management across the school to ensure the implementation of standardized and qualified educational and scientific research processes, as well as community service, in line with the national and international standards to achieve the requirements of the labor market.
  • QAU objectives:
    1. To promote awareness of QA principles and quality culture throughout the school.
    2. To deliver QA standards align to Newgiza overarching vision and mission statements.
    3. To detect and manage deficiencies and report improvements.
    4. To support the continuous quality improvement of the education process.
    5. To improve the performance of all school members.
    6. To ensure that the school is well prepared to get the accreditation.
  • QAU Organogram:

  • QAU Training and awareness activities:

    1.  Climate change Global crisis. Read more here
    2.  Digital Health. Read more here
    3.  CV writing, and interview skills. Read more here
    4Sclerosis Multiple. Read more here
    5.  Is the pandemic over? Read more here
    6.  Sustainability in University Ranking. Read more here
    7.  TAs Performance Appraisal. Read more
    here
    8.  Accelerate your science research and education with Journal of
    (visualized experiment). Read more here
    9.  Awareness lecture on rationalizing water consumption. Read more here
    10. How to use the Excel? Read more here
    11.  First Aids. Read more here
  • Leadership and Governance:
    1. Scientific research ethics guide Read more here
    2. Intellectual property rights guide Read more here
    3. SOP Job description Read more here
    4. Criteria for selecting academic leaders Read more here 
  • Academic Standards adopted:
    NARS Read more here

Tuition Fees:

The School of Pharmacy tuition fees for the academic year (2023-2024): EGP 123,600 + 500 USD for Egyptian students. For more information, please click here.

 

Deadlines:

The deadline for the academic year 2023/2024 will be announced soon.

Fill out the online application form.

For more information about the application process and how to apply to the School of Pharmacy, please visit the Admissions section.

Prof. Manal Mohamed Maher

Dean School of Pharmacy
Load Profile

Prof. Osama Hussein Kamel

Professor of Clinical Pharmacy and Pharmacy Practice
Load Profile

Prof. Marwa Fouad

Professor of Pharmaceutical Chemistry
Load Profile

Prof. Rania Mohsen Abdulsalam

Professor of Pharmacology and Toxicology
Load Profile

Prof. Nevine Shawky

Professor of Pharmaceutics and Industrial Pharmacy
Load Profile

Prof. Ahmed Sherif Attia

Professor of Microbiology & Immunology
Load Profile

A/Prof. Mohamed AbouGhaly

Ass. Professor of Pharmaceutics and Industrial Pharmacy
Load Profile

A/Prof. Ayman Elsayed Elsahar

Ass. Professor of Pharmacology and Toxicology
Load Profile

A/Prof. Amr M. Saadeldeen

Associate Professor Pharmacognosy and Natural Products
Load Profile

A/Prof. Carol Yousry Ghattas

Ass. Prof. of Pharmaceutics and Industrial Pharmacy
Load Profile

A/Prof. Rabab Hamad Sayed

Ass. Professor of Pharmacology and Toxicology
Load Profile

A/Prof. Amr M. Mahmoud Bekhet

Ass. Professor of Analytical Chemistry
Load Profile

Dr. Reham Mohamed Essam El-Wasly

Lecturer of Pharmacology and Toxicology
Load Profile

Dr. Sally A. Tadros

Lecturer of Biochemistry and Molecular Biology
Load Profile

Dr. Mohamed Salah

Lecturer of Pharmaceutical chemistry
Load Profile

Dr. Heba Ali

Lecturer of Clinical Pharmacy
Load Profile

Dr. Rehab Moustafa

Lecturer of Microbiology and Immunology
Load Profile

Dr. Radwa Ewaisha

Lecturer of Microbiology and Immunology
Load Profile

Dr. Ahmed Magdy

Lecturer of Pharmaceutics and Industrial Pharmacy
Load Profile

Dr. Reham Karkeet

Lecturer of Clinical Pharmacy
Load Profile